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INTRODUCTION 
Translation is the process of protein synthesis that produces the different classes of 
proteins with various biochemical properties and cellular functions. Overall, the translational 
process requires the coordinated participation of over 100 macromolecules, including transfer 
RNAs (tRNA) that carry amino acids attached to their 3'-terminal adenosine, components of 
the ribosome, the translational factors, etc. Two domains of a tRNA molecule, the 
anticodon and the acceptor stem (especially the 3'-CCA end) actively participate in the 
translational process (Sprinzl and Cramer, 1979). tRNAs decode genetic information 
through base pairing of their anticodons with the codons of a programmed messenger RNA 
(mRNA) on the ribosome, and they transfer amino acids into a growing polypeptide chain 
through the interaction of 3'-CCA of tRNA with ribosomal proteins/RNA. Thus, transfer 
RNA molecules play a central role in gene expression to ensure the efficiency and fidelity of 
protein synthesis. 
The eflBciency and fidelity of protein synthesis depend not only on events occurring on 
the ribosome, but also on the accuracy of each tRNA molecule being aminoacylated with its 
cognate amino acid, a reaction catalyzed by aminoacyl-tRNA synthetases. Since all tRNAs 
adopt similar L-shaped tertiary structures, each aminoacyl-tRNA synthetase must specifically 
recognize its cognate tRNA while effectively discriminating against all others. The specific 
and accurate aminoacylation of a tRNA by its cognate synthetase is governed by a number of 
nucleotides in a tRNA; these nucleotides are referred to as "identity elements". Over the 
years, a number of biochemical, biophysical, and genetic approaches have been developed 
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and refined to study the structure-function relationships of tRNA molecules in the 
aminoacylation reaction (Saks et ai, 1994; Giege et al., 1993). In the present study, 
structure-function relationships of E. coli tRNA^** were determined by studying the steady-
state kinetics of aminoacylation of in vitro transcribed tRNA variants. This study also 
examines the role of the universally conserved 3'-CCA sequence of tRNA^** in polypeptide 
synthesis. In particular, the role of 3'-end of tRNA^"* in ternary complex formation with 
elongation factor Tu was examined in depth. 
Transfer RNA: Structure and Functions 
Structure of tRNA 
Determination of the sequence of yeast tRNA'^ in 1965 marked the first such 
achievement for any RNA molecule (HoUey et al., 1965). From the sequence information, it 
was inferred that tRNAs can fold into a cloverleaf secondary structure (Figure lA). 
Currently, there are almost 2000 tRNA or tRNA gene sequences known from more than 200 
organisms and organelles (Gesteland and Atkins, 1993). Girheimer ef a/.(1995) have 
reviewed the general features of the primary and secondary structure of tRNA. The 
cloverleaf structure of tRNA has about half of its nucleotides base paired to form four helical 
stems; the acceptor stem, D-stem, T-stem, and anticodon stem. Five groups of unpaired 
nucleotides comprise four loops and one single stranded region; these are the D-loop, the T-
loop, the anticodon loop, the variable loop, and the 3'-NCCA end. The acceptor stem 
contains both of the 3' and 5' termini of the tRNA, and has the amino acid attachment site at 
the 3'-terminal A of the universally conserved 3'-CCA sequence. The anticodon base triplet. 
Figure 1. General tRNA staicture. (A) Cloverleaf structure with bases replaced by numbers indicating the standard 76 nucleotide 
positions. Invariant and semi-invariant positions are designated by nucleotide symbols or R for purine, Y for pyrimidine, 
H for highly modified purine. Tertiary base pairs are indicated by solid lines. (B) L-shaped structure of yeast tRNA"". 
The structure was generated by the program RasMol (R. Sayle) based on the yeast tRNA*^ structure (Jack and Levitt, 
1978); Brookhaven Databank access code 4tna. 
A 
3'  
5' 
D Loop 
a /li R 
D Stem 
A 
C 
C 
73 
1-72 
2-71 
3-70 
4-69 
5-68 
6-67 
7-66 
Amino Add 
Attachment Site 
Acceptor Stem 
T Stem 
65 64 63 62 C 
51 52 G T 
TLoop 
59 
variable 
6 Loop 27-43 
?ft-A1 
R 
Anticodon Stem 30-40 31-39 
32 
U 
38 
H 
343536 
Anticodon 
B 
T Loop 
T Stem Acceptor Stem 
• V I  
D Loop 
Variable 
Loop 
Anticodon 
Stem 
35 Anticodon 
5 
located in the anticodon loop, possesses the necessary information to recognize the codon on 
mRNA. There are 15 invariant positions that always contain the same base, and eight semi-
invariant positions that always have either a purine or a pyrimidine (Figure 1 A). The chain 
length of the known tRNAs varies from 72 to 95 nucleotides. Transfer RNAs of different 
length are able to conform to the cloverleaf structure because the additional nucleotides are 
accommodated in the variable loop and variable regions in the D-loop. The number of 
nucleotides in each stem and loop is generally constant except for the variable loop and the 
D-loop. Class I tRNAs contain 4 to 5 nucleotides in the variable loop, while class II tRNAs 
can have up to 21 nucleotides in this loop. The a and P regions in the D-loop (Figure lA) 
vary m length from I to 3 nucleotides in different tRNAs. 
An interesting characteristic of tRNAs is their high content of modified nucleosides 
which display a wonderful array of structural variations (Bjork, 1995). The degree of 
modification varies with the source of the tRNAs. In human tRNAs, up to one fourth of the 
bases may be modified whereas in bacterial tRNAs there is much less nucleoside 
modification. An imino proton NMR study showed that nucleoside modifications of E. coli 
tRNA^"* stabilize the binding of magnesium ions in tRNA^"^ (Yue et al, 1994). The role of 
modified nucleosides is generally unclear, although a number of them have been implicated in 
processes ranging from restriction and expansion of codon recognition, to specific 
recognition by aminoacyl-tRNA synthetases. An example is the nucleoside modification of 
cytidine, C, to lysidine (2-lysylcytidine), L, at the first position of the anticodon of E. coli 
tRNA^*^ (Muramatsu et al., 1988). By this single modification, the codon specificity is 
switched from the methionine codon, AUG, to an isoleucine codon, AUA, and at the same 
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time, the aminoacylation identity of the tRNA is switched from methionine to isoleucine 
(Muramatsu e/a/., 1988). 
The first high resolution X-ray crystal structure, that of yeast tRNA*^ at 3 A, was 
solved in 1974 (Figure IB) (Kim et ai, 1974; Robertus et al, 1974). Kim (1976) has 
reviewed the general features of the three-dimensional structure of yeast tRNA"^. From X-
ray crystallographic studies, the backbone structure of yeast tRNA*^ was found to have 
several characteristics; (1) the molecule has the overall shape of the letter "L"; (2) helical 
stems implied by the cloverleaf secondary structure are maintained in the three dimensional 
structure; (3) the acceptor and T stems form a continuous double helix, the D and anticodon 
stems form another continuous double helix, and the two continuous double helices are 
approximately perpendicular to each other; (4) the 3'-CCA and anticodon are located at the 
two ends of the "L"; (5) the D and T loops come near each other to form the comer of the 
"L". The overall dimension of a tRNA molecule places the 3'-CCA and the anticodon loop 
of tRNA approximately 75 A apart. 
There are a total of nine tertiary interactions, involving 21 nucleotides, that contribute 
to the folded L-shaped structure of yeast tRNA"" (Figure IB). Four of the tertiary 
interactions are formed by conserved nucleotides; U8-A14, G18-U55, G19-C56, and U54-
A58 (Figure lA) (Grosjean et al., 1982). The remaining five tertiary interactions are formed 
by semiconserved nucleotides at positions 15-58, 13-22-46, 9-23-12,45-10-25, and 26-44 
(Figure 1 A). In E. coli tRNA^**, the nucleotides involved in tertiary interaction are the same 
as the ones found in yeast tRNA"*, except for positions 26-44 where E. coli tRNA^®* has 
A26-G44 instead of the G26-A44 found in yeast tRNA"*. From the structure of yeast 
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tRNA*^, it is shown that almost all the bases are stacked. It is believed that these extensive 
stacking interactions are the primary source of the stabilizing force maimaining the three 
dimensional structure of the tRNA, and this extensive stacking is expected to be a general 
feature for all tRNAs (Kim, 1976). 
Functions of tRNA 
Many biological properties of tRNAs are well defined. From its biosynthesis to its 
flmctions on the ribosome, tRNA molecules interact with many different proteins, including 
aminoacyl-tRNA synthetase and elongation factors (Soil and RajBhandary, 1995). 
Translation of the nucleotide sequence of mRNA into the amino acid sequence of proteins, an 
important process in the dogma of molecular biology, is mediated by tRNAs, ribosomes and 
factors. The role of tRNA in protein synthesis has been reviewed by Pongs (1978) and 
Noller (1991). During the translational process, there are three important phases; initiation, 
elongation, and termination. In£. coli, the 70S ribosome consists of SOS and SOS subunits. 
Before participating in the translational process, a tRNA molecule is aminoacylated with a 
specific amino acid by its cognate aminoacyl-tRNA synthetase, forming an aminoacyl-tRNA. 
The aminoacylation reaction, carried out in two steps, is important in the overall protein 
biosynthetic pathway. 
Amino Acid + ATP <-> Aminoacyl-adenylate + PP, 
Aminoacyl-adenylate + tRNA Aminoacyl-tRNA + AMP 
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In the first step of the reaction, the synthetase catalyzes the activation of its cognate amino 
acid, using a molecule of ATP to form an aminoacyl adenylate. In the second step, the amino 
acid is transferred from the aminoacyl adenylate to a hydroxyl group on the 3'-terminal 
nucleotide of the cognate tRNA. 
In the initiation phase, the initiator tRNA, formybnethionyl-tRNA^''*, forms a 308 
initiation complex involving the 3OS ribosomal subunit and the mRNA. This 3OS initiation 
complex is joined by the 508 ribosomal subunit to form a 708 initiation complex. Formation 
of the initiation complexes is facilitated by the initiation factors (IF-1, IF-2 and IF-3) and 
GTP. In the elongation phase, aminoacyl-tRNAs form a ternary complex with elongation 
factor Tu (EF-Tu) and GTP; formation of the ternary complex prevents the spontaneous 
hydrolysis of the unstable ester linkage in aminoacyl-tRNA. The ternary complex binds to the 
A-site of the ribosome, directed by proper recognition between the anticodon and codon. 
This codon-anticodon recognition process determines the identity of an amino acid 
incorporated at each position of the polypeptide chain. Upon binding of the aminoacyl-tRNA 
to the ribosomal A-site, GTP is hydrolyzed to GDP and EF-Tu is released from the ribosome 
in the form of the binary complex, EF-Tu;GDP. This binary complex has a low affinity for 
both the ribosome and aminoacyl-tRNA. Following binding of aminoacyl-tRNA at the 
ribosomal A site, the amino group of the amino acid initiates a nucleophilic attack on the 
carboxyl group of peptidyl-tRNA in the P-site, resulting in formation of a peptide bond. This 
reaction occurs at the peptidyltransferase center of the 508 ribosomal subunit and may be 
catalyzed by ribosomal RNA (Noller, et al., 1992; Samaha, et ai, 1995). The peptidyl-tRNA 
is then translocated from the A-site to the P-site, leaving an empty A-site ready for the next 
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round of the elongation cycle. This translocation from A-site to P-site is catalyzed by 
elongation factor G (EF-G) and also requires GTP. Uncharged tRNA leaves the P-site and 
moves to the exit site (E-site) before dissociating from the ribosome. Translation is 
terminated by release factors that recognize the termination codons and cause the hydrolysis 
of the ester bond of peptidyl-tRNA. 
Besides the very important role of tRNA in the translational process, tRNA molecules 
also participate in a variety of other fimctions in cellular metabolism such as cell wall 
biosynthesis, chlorophyll and heme biosynthesis, and as primers for retroviral RNA-direaed 
DNA synthesis, including that of HTV. These functions have recently been reviewed by Soli 
(1993). This versatility in the function of this small RNA molecule is one of the fascinating 
aspects of tRNAs. 
Role of 3'-CCA Sequence of tRNA in Aminoacylation Reaction 
The 3'-CCA sequence of tRNA is conserved in all tRNA species from prokaryotic to 
eukaryotic species. A number of previous studies on the structure of the 3'-CCA sequence of 
tRNA involved biochemical and biophysical techniques including chemical modifications, x-
ray diffraction, and NMR. These results have shown that the 3'-CCA end of tRNA has an 
ordered structure that is stabilized by vertical stacking of the bases onto the acceptor stem 
(Sprinzl and Cramer, 1979). An ordered structure of the 3'-CCA sequence may be important 
for determining the spatial arrangement of the 3'-adenosine to facilitate the interaction of the 
3'-CCA with other macromolecules, such as aminoacyl-tRNA synthetases, elongation factors, 
and components of the ribosome. Previous studies, using chemical and enzymatic 
modifications, have found that the 3'-CCA sequence is important for aminoacylation of a 
tRNA by its cognate synthetase (Sprinzl and Cramer, 1979). Modifications of either the 
adenine base (Best and Noveili, 1971; Rether et al., 1974) or ribose moiety (Cramer et ai, 
1968; Uziel and Jacobson, 1974) of the 3'-terminal nucleotide of tRNA resulted in a 
complete loss or a dramatic decrease in aminoacylation activity of tRNA. Modifications of 
the cytidines at positions 74 and 75 have different effect on the aminoacylation activities of 
the modified tRNAs depending on the type of modifications. Yeast tRNA^" having the 3'-
UUA sequence was shown to be actively aminoacyiated (Kucan et al., 1973). Introduction 
of a bulky substitution such as an alkyi group into position 75 of tRNA"" inhibited the 
activity of this modified tRNA (Sprinzl et al., 1978). In many cases, the Km values of 
modified tRNAs remain unchanged, while the Vma values are appreciably lowered. 
Effects of systematic mutations of all three bases of the 3'-CCA sequence in tRNA^"* 
have been investigated in the aminoacylation of tRNA^*' by valyl-tRNA synthetase (Liu and 
Horowitz, 1994). Most in vitro transcripts of tRNA^®* with altered 3'-termini are readily 
aminoacyiated. The presence of guanosine at position 75 or 76 severely impaired the 
aminoacylation activities of these two mutants, and tRNA^®' with a 3'-UUA sequence is also 
a very poor substrate for ValRS. Tamura et al. (1994) had also performed a systematic study 
on the role of 3'-CCA sequence of tRNA^"^ in aminoacylation and found similar results. 
Moor et al. (1994) had found that E. coli and T. thermophilns tRNA'''" with 3'-UUA and 3'-
CCC sequences are substrates for their respective synthetases; tRNA^*"® with 3'-AAA was a 
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poor substrate, and tRNA^ with 3'-UUU sequence was inactive in aminoacylation by either 
enzyme. 
Previous studies showed that the 3'-CCA sequence of tRNA is important for the 
aminoacylation activity of the molecule. These studies showed that the same modifications 
introduced into the 3'-CCA sequence of different tRNAs have different effects on the 
aminoacylation activity of tRNAs, suggesting that the modes of interaction between the 3'-
CCA sequence of different tRNAs and their cognate synthetases differ. 
Aminoacyi-tRNA Synthetases 
There are 20 aminoacyl-tRNA synthetases in E. coli, and each enzyme is responsible 
for the specific aminoacylation of one or more isoaccepting tRNAs with a cognate amino 
acid. Although the aminoacyl-tRNA synthetases catalyze the same reaction and use ATP as a 
common substrate, their molecular weights and structural assemblies are very diverse. Amez 
and Moras (1997) have recently summarized the characteristics of the aminoacyl-tRNA 
synthetases. These enzymes exhibit different types of quaternary structures: a, az, 04, and 
a.2^2 The size of the polypeptide chain ranges from 334 amino acids for a subunit of 
homodimeric (02) tryptophanyl-tRNA synthetase (Hall et al., 1982) to 1112 amino acids in 
phenylalanyl-tRNA synthetase (Mechulam et al, 1984). Sequence comparison in addition to 
structural analysis of a limited number of three-dimensional structures allowed the 
classification of the synthetases into two major classes of ten synthetases each (Eriani et al., 
1990). Class I synthetases have two conserved sequence motifs, HIGH and KMSKS (Brick 
et ai, 1989; Bninie et al., 1990; Rould et al., 1989), that are involved in ATP binding. The 
active site of class I synthetases has the classic dinucleotide (or Rossmann) fold consisted of a 
six-stranded parallel P sheet (Rossmann et al., 1976). The ten synthetases in class II do not 
have the two class I sequence motifs. Instead, they share other conserved sequence motifs 
called motif 1,2, and 3 (Cusack et ai, 1990; Ruff et ai, 1991). Both motifs 2 and 3 are part 
of the active site that features a seven-stranded antiparallel P sheet surrounded by a helices. 
This classification of the synthetases based on sequence and structural information also has a 
functional significance. All class I synthetases attach amino acids to the 2'-OH group of the 
terminal adenosine of the tRNA, whereas all but one class 11 synthetases attach amino acids 
to the 3'-0H group. Phenylalanyl-tRNA synthetase, a class U synthetase that attaches 
phenylalanine to the 2'-0H, is the only exception (Moras, 1992). 
In addition to the major classification of aminoacyl-tRNA synthetases, class 1 or class 
II synthetases can be further divided into subgroups based on additional common structural 
features (Delarue and Moras, 1993). GlnRS, GluRS and ArgRS are in a subgroup of class I 
synthetases, and this subgrouping also corresponds to the fact that they are all specific for 
charged amino acids and require a bound tRNA for amino acid activation (Ravel et ai, 
1965). Another subgroup comprises synthetases for aromatic amino acids. TyrRS and 
TrpRS. ValRS is in a subgroup with four other synthetases. IleRS, LeuRS, CysRS and 
MetRS. For the class II synthetases, AspRS, AsnRS, and LysRS are in a subgroup that 
contains consensus sequences at the amino terminus. SerRS, ProRS, ThrRS, and HisRS are 
in a subgroup that shares homologies at their carboxy termini. Finally, GlyRS, PheRS, and 
AlaRS are grouped into a subgroup that shows distinctive quaternary features 
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Recognition of tRNAs by Aminoacyl-tRNA Synthetases 
Methodolo2v For Studying Recognition of tRNA bv Aminoacvl-tRNA Synthetase 
tRNAs are well-characterized RNA molecules of known three dimensional structure 
based on the crystal structure of yeast tRNA^. Because of the structural similarity of the 
tRNAs, and the chemical similarity of aminoacylation systems, the discrimination of tRNA 
molecules by aminoacyl-tRNA synthetases (aaRS) remains a challenging and intriguing 
problem in molecular recognition (McCIain, 1993; Giege et al., 1993). 
There are two general approaches utilized by researchers in this field to study the 
identity of tRNAs. Both methods involved the genetic engineering of tRNA genes in vitro to 
produce mutants at specific positions in a tRNA molecule. Recognition of tRNA by 
synthetase is then determined by either examining the fiinction of mutant amber suppressor 
tRNAs in vivo, or by studying the aminoacylation kinetics of in vitro transcripts of mutant 
tRNAs. In vivo assays of amber suppressor tRNA activity use a mutant dihydrofolate 
reductase gene as a reporter protein. In this mutant dihydrofolate reductase mRNA, the 
codon for the amino acid at position 10, near the amino terminus, is replaced by an amber 
termination codon (CUA) (Normanly et ai, 1986). The amino acid specificity of mutant 
suppressor tRNAs is then determined by identifying the amino acid inserted at position 10 
(amber site) of dihydrofolate reductase by amino acid sequence analysis. Schulman (1991) 
has reviewed identity elements of several tRNAs obtained by the in vivo approach. 
The inability to test tRNAs containing wild type anticodons is a major drawback of 
the in vivo amber suppressor assay. A major advance in the in vitro synthesis of RNA was 
the use of phage promoters and phage RNA polymerases (Melton et al., 1984). Currently, 
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the method of choice, first employed by Sampson and Uhlenbeck (1988) in the study of yeast 
tRNA*^ for in vitro tRNA recognition studies, uses the T7 promoter and T7 RNA 
polymerase for the nm-off transcription of a cloned tRNA gene. The aminoacylation activity 
of many of the in vitro transcribed tRNAs with wild type sequences is very similar to that of 
their native counterparts, even though they lack all of the naturally occurring nucleoside 
modifications. This is true TOTE. coll tRNA^** (Chu and Horowitz, 1988) which is used in 
the present study. Typically, in vitro recognition studies are carried out by measuring the 
rate of aminoacylation of tRNA variants with base substitutions at positions under 
investigation. The relative efiBciency of a tRNA as a substrate for an aminoacyl-tRNA 
synthetase is evaluated by comparing A:cat/ K^or Vmw/K„, the "specificity constant." 
Synthetase Recognition Elements of tRNA 
A long-standing question in the study of tRNA identity has been: What is the 
molecular basis by which an aminoacyl-tRNA synthetase recognizes its cognate tRNAs with 
such a high degree of precision, and discriminates against other tRNAs with similar overall 
secondary and tertiary structures? Specificity of the genetic code depends absolutely on the 
attachment of a correct amino acid to a tRNA by the corresponding aminoacyl-tRNA 
synthetase (aaRS) (Schimmel, 1989; Normanly and Abelson, 1989). Despite the relatively 
large number of nucleotides in tRNAs, experimental results indicate that only a limited 
number of nucleotides contribute to the specific recognition of tRNAs by cognate 
synthetases. Many studies have been carried out, in E. coli at least, which allow a general 
pattern of tRNA recognition to emerge. In most tRNAs, the anticodon, the discriminator 
base, and parts of the acceptor stem sequences are implicated in the recognition process 
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(Pallanck et al., 1995; Saks et al., 1994). Each tRNA is believed to contain within its 
sequence a set of'recognition nucleotides' that allows productive recognition and 
aminoacylation by the cognate synthetase and perhaps another set of'negative determinants' 
that blocks the aminoacylation of non-cognate tRNAs. Together these define the 'identity 
elements' of a tRNA. A great deal of progress has been made in locating the nucleotides of 
particular tRNA molecules that specify aminoacylation identity. 
Anticodon recotmition 
Since the anticodon positions 34, 35, and 36 specify the decoding capacity of a tRNA, 
it would seem to be a natural place to specify tRNA acceptor identity as well (Fralova and 
Kisselev, 1964). The role of the anticodon in the aminoacylation of tRNA has recently been 
reviewed by Pallanck et al. (1995). Significant reductions in aminoacylation activities 
following nucleotide replacements in the anticodon have been observed for 15 of 20 E. coli 
tRNAs; those for Arg, Asn, Asp, Cys, Gin, Gly, His, lie. Met, Phe, Pro, Thr, Trp, Tyr, and 
Val (amino acids designated by their three-letter codes). Two additional tRNAs, GIu and 
Lys, also have reduced activity upon base substitutions in the anticodon, but to a lesser 
degree. In the case of tRNA'^' and tRNA^, the cognate synthetase does not interact with 
the anticodon loop. For some tRNAs, such as tRNA°°, tRNA^'"*, and tRNA"^, nucleotides at 
all three positions of the anticodon are important for recognition. In others, such as tRNA^, 
tRNA°'^, and tRNA^**, only two nucleotides of the anticodon are important for recognition. 
The effect of base substitutions in the anticodon varies fi'om one tRNA to the next, possibly 
reflecting the relative importance of the anticodon in recognition of different tRNAs. While 
in most cases base modification of nucleotides in the anticodon is not essential for the 
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recognition of tRNAs by their cognate synthetases, in the case of E. coli tRNA°° it is the 
modified base lysidine, a derivative of cytidine, that is recognized by isoleucyl tRNA 
synthetase (Muramatsue/a/., 1988). 
Although a decrease in aminoacylation on nucleotide substitution may indicate that a 
recognition element has been eliminated, other interpretations are possible, e.g., effects on the 
tertiary structure of tRNA. The most convincing way to demonstrate that an anticodon 
dictates the aminoacylation of a tRNA is to replace the anticodon of one tRNA with that of 
another and show that the amino acid acceptor identity of the tRNA coincides with the 
anticodon. Schulman and Pelka (1988) performed a series of elegant experiments that 
constitute "identity swap experiments" to show the contribution of the anticodon to the 
identity of£. coli tRNA^''(UAC) and tRNA'^*"(CAU). Sampson et al. (1989) have 
successfiilly demonstrated, with identity swap experiments, that five nucleotides are all that 
are required for the specific recognition of yeast tRNA^ by phenylalanyl-tRNA synthetase 
(PheRS), provided that these recognition nucleotides are positioned correctly in the 
secondary and tertiary structures of the tRNA. 
How do nucleotides in the anticodons contribute to the recognition of tRNAs? 
Biochemical studies oftRNA-synthetase complexes suggest conformational changes in the 
anticodon of tRNAs during aminoacylation (Frugier et al., 1992). Crystallographic studies of 
the E. coli tRNA°'°-GlnRS (Rould et al., 1991) and the yeast tRNA'^ -AspRS (Ruff et al., 
1991) complexes show significant conformational changes in the anticodon loop of the 
tRNAs as a result of tRNA-synthetase interaction. Since the anticodon is the important 
identity site in many tRNAs, it is believed that the effects of recognition of anticodon 
determinants must be transmitted to the synthetase's catalytic site, about 75 Aaway from the 
anticodon of the tRNA, by conformational changes of the synthetase, the tRNA or both. 
Ivana et al. (1994) identified, by genetic selection, a 17 amino acid loop that is required for 
transferring the information of anticodon recognition to the active site of glutaminyl-tRNA 
synthetase (GhiRS). Rogers et al. (1994) also found amino acid residues interacting with the 
inside of the L-shaped tRNA to be responsible for the role of transmitting anticodon 
recognition to the active site of GInRS. 
Acceptor stem and discriminator base recognition 
The acceptor stem and the discriminator base (position 73) of a tRNA, because of 
their close proximity to the catalytic site of aminoacyl-tRNA synthetases, would also be 
logical locations for identity elements. For 17 out of 20 E. coli tRNAs, all except tRNA"", 
tRNA^, and tRNA^ the discriminator base serves as a recognition nucleotide (reviewed by 
Pallanck et al., 1995). Base pairs in the acceptor stem also have been found to contain 
important recognition elements for many tRNAs, including E. coli tRNA'^', tRNA^*", 
tRNA°'\ tRNA"", and tRNA^. For tRNA'^', a G;U base pair in the 3:70 positions of the 
acceptor stem is the most important identity element (Hou and Schinmiel, 1988; McClain and 
Foss, 1988). In fact, a RNA minihelbc (Francidyn and Schimmel, 1989), a 12-base pair stem 
and loop RNA molecule that consisted of sequences from the acceptor stem and the T-stem 
and loop of tRNA'^* plus the 3'-ACCA terminus, as well as a small RNA molecule with a 
four-base pair stem (same sequence as the first four base pairs in the acceptor stem of 
tRNA'^") connected by a tetraloop and the 3'-ACCA terminus (Shi et al., 1992) are 
substrates for alanyl-tRNA synthetase provided that the G3 .U70 base pair is present. The 
18 
minihelix shows only a five-fold reduction in aminoacylation activity compared to fiill-length 
tRNA'^'. Other studies showed that the first three base pairs in the acceptor stem of tRNA^ 
are important identity elements of this tRNA (Normanly et al., 1986). tRNA"" is unique 
among E. coli tRNAs in having an extra base pair in the acceptor stem (-1:73), and as a 
result, this tRNA contains 8 base pairs in its acceptor stem. The -1G:C73 base pair is 
important for the aminoacylation of this tRNA (Himeno et ai, 1989). 
Variable pocket and variable loop recopiitinn 
In the crystal structure of yeast tRNA^ (Kim et ai, 1974; Robertus et al, 1974), 
nucleotides 16, 17, 20, 59 and 60 reside in close proximity to one another and form a so-
called variable pocket. In addition to the anticodon loop, the acceptor stem and the 
discriminator base, recognition nucleotides in the variable pocket and the variable loop have 
been identified in a few tRNAs. In E. coli tRNA'^, besides the major recognition nucleotides 
at all three positions of the anticodon, positions 20, 59 and 60 in the variable pocket and 
positions 44 and 45 in the variable loop all contribute modestly to recognition (Peterson and 
Uhlenbeck, 1992). Furthermore, position 20 of yeast tRNA^*^ was found to be involved in 
recognition by yeast PheRS, in addition to position 73 and the major recognition nucleotides 
in the anticodon (Sampson et ai, 1989). In E. coli tRNA'^®, position 35 is the major identity 
element for synthetase recognition, however A20, a nucleotide found exclusively in E, coli 
tRNA'^ isoacceptors (McClain et ai, 1990), was shown to be important for recognition, by 
in vivo studies (McClain and Foss, 1988; Normanly et ai, 1990). 
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Importance of structural features in tRNA recognition 
Although tRNAs have similar global structure as dictated by the common protein 
synthesis machinery, there are subtle conformational differences among tRNAs. Giege et al. 
(1993) have summarized some examples of conformational features of a tRNA that influence 
aminoacylation eflBciency. It has been found that transplantation of foreign tertiary 
interactions into the sequence context of yeast tRNA"^ has little effect on the steady-state 
aminoacylation kinetics catalyzed by PheRS (Sampson et al., 1990). However, 
transplantations of tertiary interactions found in yeast tRNA'^ into yeast tRNA"^ alter the 
conformation of the tRNA, based on lead mapping studies (Perret et al., 1992). Studies on 
identity swap experiments with yeast tRNA'^ and tRNA^ reached some general 
conclusions: (1) transplantation of the identity set may not be sufficient to confer optimal 
new specificity, (2) synthetases have variable sensitivities to the conformation of their tRNA 
substrates, (3) manipulation of tRNA conformation can overcome some of the constraints 
that attenuate the efl5ciency of the specificity switch. More recently, Senger and Fasiolo 
(1996) also found that tRNA tertiary structure makes an important contribution to the 
identity of yeast tRNA^^'. The importance of tertiary interactions and the conformation of 
tRNA in the aminoacylation reaction has begun to attract more attention in the studies of 
synthetase recognition nucleotides in tRNAs. 
Synthetase RecoEPition Elements of E. coli tRNA^** 
The role of the anticodon of tRNA^** (Figure 2) in ValRS recognition has been very 
well established (Schuhnan and Pelka, 1988; Tamura et al., 1991; Chu et al., 1992). A35 and 
C36 are the major synthetase recognition determinants of tRNA^"' McClain and Nicholas 
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Figure 2. Cloverleaf structure of E. colt tRNA^*' (shown without modified bases). 
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(1987) used computer analysis to identify nucleotide positions that offer distinguishing 
characteristics of each tRNA acceptor type. Based on the available E. coli and Salmonella 
tRNA sequences, their analysis suggested that possible recognition nucleotides for tRNA^*' 
are A3 5 and C36 in the anticodon loop, the U4:A69 base pair in the acceptor stem, the 
C30;G40 base pair in the anticodon stem, G44 in the variable loop, and the C51 ;(J63 base 
pair in the T-stem. Schuiman and Pelka (1988) suggested that additional nucleotides outside 
of the anticodon may make some contribution to tRNA^®* identity, since tRNA""^'®* with a 
tRNA^"^ anticodon, UAC, is only one tenth as efficient a substrate for ValRS as wild type 
tRNA^*'(UAC). The acceptor stem of tRNA^®* makes contact with ValRS during the 
aminoacylation reaction, as suggested by an NMR study of ValRS interaction with 5-
fluorouracil (FU) modified tRNA^"' (Chu and Horowitz, 1991) and by nuclease footprinting 
studies on tRNA^"* (Derrick, 1991). More recently, Liu (1995) has identified A73 and G20 
as additional recognition nucleotides of tRNA^''. Experimental results in our laboratory 
indicate that the eight modified bases in native E. coli tRNA^®* do not play a significant role 
in the recognition process (Chu and Horowitz, 1989). Furthermore, incorporation of the 
uracil analog, 5-fluorouracil (FU), into tRNA^ "' and the complete assignment of the NMR 
spectrum of 5-fluorouracil-substituted tRNA^®* make NMR a powerful tool for probing 
the solution structure of FU-substituted tRNA^*' (Chu and Horowitz, 1991; Chu et al., 
1992). 
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Recognition of tRNAs by Elongation Factor Tu 
Biochemical Studies of Aminoacvl-tRNA and Elongation Factor Tu Interaction 
During protein synthesis in bacteria, elongation factor Tu recognizes, transports, and 
positions the codon-specified aminoacyl-tRNA onto the A site of the ribosome. In order for 
the elongation process of translation to occur, elongation factor Tu has to recognize all 
aminoacylated elongator tRNA molecules in the cell (Faulhammer and Joshi, 1987). Ternary 
complex formation of aminoacylated elongator tRNA with elongation factor Tu is a crucial 
step for cell viability since formation of this complex permits the controlled entrance of 
aminoacyl-tRNA into the elongation cycle (Clark et al., 1990). 
Elongation factor Tu (EF-Tu) of E. coli is a monomeric protein with a molecular 
mass of 43,200 daltons, containing 393 amino acid residues. The structure of EF-Tu in the 
GDP form (Clark et al., 1990) consists of three domains, in a triangular arrangement. 
Domain I has residues 1-200 and is roughly spherically shaped. It is the site of the GTPase 
activity of the molecule and is therefore called the G domain (Bourne et al., 1991). Domain 
II (residues 209-299) and domain III (residues 300-393) are barrel-shaped. EF-Tu is the 
most abundant protein in the E. coli cell, comprising about 5% of the total cellular proteins. 
The high level of EF-Tu is needed to sequester aminoacyl-tRNAs and prevent wasteful 
hydrolysis of the aminoacyl linkage to tRNA. This excess of EF-Tu over aminoacyl-tRNA 
also increases the accuracy of translation (Pingoud et al., 1990). 
Since all tRNA sequences differ from each other, except for a set of conserved and 
semiconserved residues involved in maintaining the classical L-shaped folding, elongation 
factor Tu has to recognize some characteristic structural features or conserved sequences 
carried by all elongator tRNA species. The process of recognition between tRNAs and 
translation factors is understood only in some limited cases. 
Nazarenko etal. (1994) reported that conserved and semiconserved nucleotides do 
not contribute significantly to the interaction of tRNA^' transcripts with EF-Tu. 
Faulhammer and Joshi (1987) have reviewed the structural features of aminoacyl-tRNAs that 
are required for recognition by elongation factor Tu. Several regions of elongator tRNAs 
have been implicated as important sites for the interaction with EF-Tu: GTP including the 
aminoacyl moiety, the 3'-CCA end, and the continuous helix of the acceptor arm domain. In 
the EF-Tu; aminoacyl-tRNA complex, the T loop and the anticodon are free and accessible 
for interaction with the ribosomal A site and the messenger RNA, respectively. Enzymatic 
probing shows that parts of the amino acid stem, the T stem, and most of the variable loop of 
tRNAs in the ternary complex are protected fi-om nuclease digestion by EF-Tu (Wikman et 
al., 1982). Cross-linking experiments suggest that parts of the T loop and stem interact 
directly with EF-Tu (Wikman et al., 1987). Furthermore, Joshi et al. (1984) demonstrated, 
using a valylated tRNA-like domain derived from turnip yellow mosaic virus RNA, that a 
RNA fragment containing the equivalent of the variable loop and the amino acid acceptor 
stem of tRNA is able to bind with E. coli elongation factor Tu and GTP. These results agree 
well with a report that aminoacylated tRNAs with the anticodon stem and loop substituted by 
a tetranucleotide, bind to EF-Tu as well as the corresponding full-length tRNAs (Nazarenko 
and Uhlenbeck, 1995). Taken together, most biochemical and biophysical studies show 
strong evidence that the T-stem, the aminoacyl stem, the 3'-NCCA end, and the variable loop 
of tRNA provide the major contact points with E. coli elongation factor Tu. Despite these 
investigations, the molecular recognition between elongator aminoacyl-tRNAs and EF-
Tu:GTP is just beginning to be understood, mainly through the recently solved crystal 
structure of a ternary complex (Nissen et ai, 1995). 
Non-elongator aminoacyl-tRNAs do not form a ternary complex with EF-Tu:GTP. 
In prokaryotes, an unusual C1:A72 mismatch at the end of acceptor stem of initiator tRNA, 
tRNA®"*", is responsible for the weak interaction of this tRNA with EF-Tu;GTP 
(RajBhandary and Chow, 1995). Mutants of tRNA®"*"^ with a Watson-Crick base pair at base 
pair 1:72 interact with EF-Tu and can act as elongator tRNAs in protein synthesis (Seong 
and RajBhandary, 1987; Seong et al., 1989). Initiator tRNA'^'" from plants and fungi are 
discriminated against by eukaryotic elongation factor la (EF-la) because they have a bulky 
2'-phosphoribosyl modification at purine 64 in the T-stem (Kiesewetter et al., 1990). In the 
discrimination against selenocysteine-specific tRNA^ by EF-Tu, the extra length of the 
acceptor stem and T-stem, 13 base pairs instead of the 12 found in other elongator tRNAs, 
was reported to be the critical factor in preventing EF-Tu binding (Baron and Bock, 1991). 
More recently, Rudinger et al. (1996) have identified three base pairs in the acceptor arm of 
tRNA^** as the antideterminants that prevent recognition of tRNA^ by EF-Tu. 
CrvstaUoCTaphic Study of a Ternary Complex 
The crystal structure of the ternary complex of yeast phenylalanyl-transfer RNA 
(phenylalanyl-tRNA"^), elongation factor Tu (EF-Tu) and the guanosine triphosphate (OTP) 
analog GDPNP at 2.7 A (Figure 3) shows many details of the recognition of aminoacyl-tRNA 
by EF-Tu (Nissen et ai, 1995). The ternary complex was found to be a trimer, but the 
authors believe that this is the resuh of crystal packing and is not of biological significance 
Figures. Structure of the ternary complex (EF-Tu:Phe-tRNA"^:GTP analogue). EF-Tu is 
depicted with spacefilled model in gray, and Phe-tRNA is shown with backbone in 
black. The 3'-CCA-Phe is emphasized with stick model and enlarged in the inset. 
The three domains of EF-Tu are labeled, I, n and m, respectively. The structure 
was generated by the program RasMol (R. Sayle) based on the crystal structure of 
ternary complex (Nissen et aL, 1995); Brookhaven Databank access code Ittt. 
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The shape of a single ternary complex resembles a corkscrew. All three domains of the 
elongation factor Tu are involved in the binding of phenylalanyl-tRNA^. However, only 
small areas of both the protein and the RNA make significant contact. In the crystallographic 
structure of the ternary complex, there are three major regions of contact involved in the 
binding of phenylalanyl-tRNA to EF-Tu:GDPNP; (1) the 3'-CCA-Phe binds to the domain I 
and II interface, (2) the 5' end and the acceptor stem of the tRNA bind at the intersection of 
the three protein domain interfaces, and (3) the T-stem binds to the surface of domain III. 
The observation that a RNA minihelix having a minimum of 10 base pairs in the helical stem 
is the smallest such structure able to form a tight complex with EF-Tu:GTP (Rudinger et ai, 
1994) agrees well with the observation in the crystal structure that the EF-Tu binding site on 
aminoacyl-tRNA covers the first 10 base pairs of the acceptor helix. Finally, the 3'-terminal 
adenosine of yeast tRNA®^, identified fi"om its electron density in the crystal structure, is 
located in a hydrophobic pocket. In this pocket, the conserved residue Glu271 stacks on one 
side of the adenine and the conserved residues Val237 and Ile231, together with Leu289 
make a hydrophobic platform for the adenine on the other side. However, EF-Tu does not 
make any base-specific contact (i.e. hydrogen bond) with the fimctional groups on the 3'-
adenine. 
Role of the 3'-CCA Sequence of tRNA in Ternary Complex Formation 
The 3'-CCA sequence of tRNA is universally conserved in all tRNAs from 
prokaryotic and eukaryotic systems. The 2'-0H or 3'-0H of the 3'-temiinal adenosine is the 
site of amino acid attachment. The presence of an aminoacyl moiety on the tRNA is essential 
for the formation of a ternary complex between an elongator tRNA and EF-Tu ;GTP 
(Gordon, 1967; Lockwood etai, 1971). However, uncharged tRNA or modified tRNAs 
lacking all or part of the 3'-CCA end were found to influence the GTPase activity of EF-Tu 
(Picone and Parmeggiani, 1983). 
Studies of the role of 3'-CCA in ternary complex formation are hindered by the fact 
that modification of the 3'-CCA sequence of tRNA often results in either a total loss or a 
dramatic decrease in aminoacylation activity of the tRNA. Sprinzl and Cramer (1979) have 
reviewed the interaction of the 3'-CCA end of tRNA with the elongation factor Tu. In one 
study, the 3'-CCA of yeast tRNA"* was extended by a cytosine to 3'-CCCA (Thang et al., 
1972). Its aminoacylation activity and its ability to form ternary complex with EF-Tu;GTP 
are severely reduced. Elongation factor Tu can form stable ternary complexes with several 
3'-CCA modified aminoacyl-tRNAs. These modifications include 5-iodocytidine (i^C) and 2-
thiocytidine (s^C). Yeast phenylalanyl-tRNA'^ -i^C-i^C-A, phenylalanyl-tRNA"" -C-i^C-A 
and phenylalanyl-tRNA*^ -C- s^C-A are active in elongation factor-dependent binding to 
ribosomes fi'om rabbit reticulocytes (Baksht et al., 1977). When the 3'-terminal adenosine of 
yeast tRNA'''"^ is replaced by formycin (F) (its absorption and fluorescence properties are 
useful in probing en2yme-substrate interactions), yeast tRNA"* -C-C-F was found to 
participate in in vitro protein biosynthesis using a rabbit reticulocyte cell-fi-ee system, 
although at a lower level of activity than that of the unmodified tRNA"* (Basksht and Groot, 
1975). Several derivatives of pyrrolopyrimidine, a class of nucleotide analogs used as 
antibiotics (Acs etal., 1964), including tubercidin, toyocamycin, and sangivamycin can be 
incorporated into the 3'-terminal position of rabbit liver tRNAs (Uretsky et al., 1968). tRNA 
molecules with either toyocamycin or sangivamycin 3'-termini were found to be very poor 
substrates in the aminoacylation reaction. Only tRNA molecules with tubercidin at the 3'-
termini had near-normal activity in aminoacylation and polypeptide synthesis. 
Recognition of aminoacyl-tRNA is severely affected by modification of the 
ribofiiranosyl moiety on the 3'-terminal adenosine. Ofengand and Chen (1972) showed in 
yeast tRNA"" that periodate cleavage of the 2',3'-carbon-carbon bond of the 3'-terminal 
adenosine did not significantly affect its aminoacylation by phenylalanyl-tRNA synthetase, but 
this ribofuranose-modified phenylalanyl-tRNA^ was unable to form a ternary complex with 
EF-Tu:GTP. This loss of activity was attributed to the conformational disturbances at the 3' 
end of tRNA as a result of opening the ribose ring (Chinali et al., 1974). 
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EXPERIMENTAL PROCEDURES 
Materials 
Bateriai Strains and Plasmids 
£". coli TGI (K12, [lac-pro], SupE, thi, hsdD5/F'traD36, proA~B*, lacI^ lacZMlS), 
used for phagemid propagation was obtained from Amersham Life Sciences. Bacteriophage 
M13K07 and phagemid pUCl 19 were gifts from Dr. Alan Myers (Iowa State University). 
Phagemid pVALl 19 is a derivative of pUCl 19 which contains a T7 promoter directly 
followed by a tRNA^*' gene (Chu and Horowitz, 1989). Phagemid pFVALI 19 is a derivative 
of pVALl 19 which has a Fok I restriction site inserted downstream of the tRNA^®* gene (Liu 
and Horowitz, 1993). Phagemid pFALAl 19 (Liu, 1995), pFPHEl 19 (Liu, 1995), 
pFYPHEl 19 are derivatives of pUCl 19 which contain a T7 promoter followed by E. coli 
tRNA'^", E. coli tRNA"", and yeast tRNA*^ genes, respectively, and a Fok I restriction site. 
Expression plasmid pQECtuf (Ribeiro et al., 1995) containing the gene for T. thermophilus 
elongation factor Tu was kindly provided by Dr. Mathias Sprinzl (Bayreuth University). 
Restriction Endonucleases and Enzymes 
Restriction endonucleases were purchased from New England Biolabs and Promega. 
T4 DNA ligase and T4 polynucleotide kinase were purchased from New England Biolabs. 
Inorganic pyrophosphatase was obtained from Boehringer Mannheim Biochemicals. Valyl-
tRNA synthetase (ValRS) was purified by Dr. Wen-Chy Chu from E. coli strain GRB238 
carrying the plasmid pHOVl (Chu and Horowitz, 1991). T7 RNA polymerase was purified 
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from E. coli BL2I/pAR12I9 according to the method ofZawadzki and Gross (1991). E. 
coli S-100 was purified by Dr. Mingsong Liu according to the method of Muench and Berg 
(1966). Purified alanyl-tRNA synthetase was a gift from Dr. Paul Schimmel (Massachusetts 
Institute of Technology). 
Nucleic Acids 
Native E. coli tRNA^"* was purchased from Subriden RNA. Unfractionated E. coli 
tRNA was from Plenum Scientific Research Inc. Nucleotide triphophates and guanosine 5'-
monophosphate for in vitro transcription were obtained from United States Biochemical Co. 
and Sigma. Deoxyoligonucleotides were synthesized by the DNA Synthesis Facility at Iowa 
State University. Automated DNA sequencing was performed by the DNA sequencing 
facility at Iowa State University. The DNA sequencing kit was from Amersham Life 
Sciences. 
Radioisotopes and Chemicals 
[^H]valine (27-32 Ci/mmol, ICi/ml), [^H]alanine (50Ci/mmoI, ICi/ml), 
[^H]phenylalanine (65Ci/mmol, ICi/ml), and deoxyadenosine 5'-a-[^^S]thiotriphosphate were 
purchased from Amersham Life Sciences. Most chemicals and antibiotics (ampicillin, 
kanamycin, and tetracyclin) were from Sigma or Fisher Chemical Co. Biosafe NA 
scintillation fluor was obtained from Research Product International. Whatman 3MM paper 
was from the Whatman Co. Ingredients for cell culture media were from Difco Chemical Co. 
All other chemicals were of reagent grade or higher. The site-directed mutagenesis kits were 
from Amersham Life Sciences and Clonetech. 
Methods 
Construction of Phagemid pFYPHE119 
p67YF0 (Sampson and Uhlenbeck, 1988), a derivative of pSP65 which contains the 
yeast tRNA^ gene, was kindly provided by Dr. Olke Uhlenbeck (University of Colorado, 
Boulder). Directional cloning was utilized to construct phagemid pFYPHEl 19 (Maniatis et. 
al., 1989). Plasmid p67YF0 was digested with 5awHI and1. A 101-mer fragment 
containing the tRNA"" gene was isolated by gel electrophoresis in 1% agarose (Amresco, 
agarose 3:1 high resolution blend). The DNA band corresponding to the insert was cut from 
the gel and purified by a gel extraction kit from Qiagen Inc. A small 44-mer DNA fragment, 
containing a Fok I restriction site, was isolated from BamYH and Hind III double digested 
pFVALl 19 by electrophoresis on a 2% agarose gel, and purified as described above. The 
vector was prepared from pVail 19 by endonuclease digestion with Pst I and Hind III, and 
the largest DNA fragment was isolated on a 1% agarose gel, and purified as described. The 
101-mer and the 44-mer were ligated into the vector with T4 DNA ligase at 16°C overnight, 
and used to transformed competent TGI cells. The sequence of the recombinant phagemid 
containing the tRNA®^ gene was confirmed by the dideoxy DNA sequencing method of 
Sanger (Sanger et al., 1980). 
Site-Directed Mutagenesis 
Site-directed mutagenesis of tRNA genes was performed either by the method of 
Eckstein (Taylor et al., 1985) using a kit from Amersham Life Sciences or by the method of 
Deng and Nickoloff (1992) using a kit from Clonetech. Mutant clones were selected by 
single-lane dideoxy sequencing (Sanger et al., 1980) or the results of endonuclease digestion 
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patterns. The sequence of tRNA mutants was confirmed by manual or automated 
sequencing. 
In vitro Transcription of tRNA Genes by T7 RNA Polymerase 
All recombinant phagemids used for in vitro transcription were purified by cesium 
chloride density gradient ultracentrifiigation (Maniatis et al., 1989) or with the plasmid 
preparation kit from Primm Labs, Cambrige, MA. BsfNI or Fok I digested phagemids served 
as template for T7 RNA polymerase. The transcription reaction was carried out in 40mM 
Tris-HCl (pH 8.0), 20 mM MgCb, 2 mM spermidine, 5 mM DTT, 50 |j.g/ml BSA, 80 jag/ml 
fis/NI or Fok I digested phagemid, 4 mM each of ATP, CTP, GTP, and UTP, 16 mM GMP, 
80 units/nl of T7 RNA polymerase, and 4 units/ml of inorganic pyrophosphatase. After 
incubation for 4 hours at 42°C, the reaction mixture was extracted twice with an equal 
volume of phenol/chloroform/isoamyl alcohol (25:24:1), followed by extraction with 
chloroform/isoamyl alcohol (24:1). Transcription products were precipitated with three 
volumes of 95% ethanol after addition of 1/10 volume of 3 M sodium acetate (pH 4.8). 
HPLC Purification of tRNA Transcripts 
Crude tRNA transcripts were separated from the unincorporated nucleotides and 
DNA fragments by HPLC on a Toyopearl DEAE-650S column (250x4.6 mm). The column 
was equilibrated with 25 mM Tris-HCl (pH 7.4) and 250 mM NaCI, and tRNA was eluted 
with a 20-ml linear gradient from 350 to 600 mM NaCl in 25 mM Tris-HCl (pH 7.4). The 
eluted tRNA was precipitated with three volumes of 95% ethanol. tRNA transcripts were 
fiirther purified by HPLC on a Vydac C4 reverse phase column (250x4.6 mm). The column 
was first equilibrated with 100% buffer A (1.0 M NH4(OAc), pH 6.0, 20 mM MgCb). After 
injection of the sample, the column was developed with a linear gradient from 100% buffer A 
to 50% buffer B (10 mM NH4(0Ac), pH 6.0, 20 mM MgCb, and 20% methanol). The 
eluted tRNA was precipitated with three volumes of 95% ethanol. Finally, the tRNA sample 
was dried in a Savant speed-vac concentrator and dissolved in TNG buffer (Tris-acetate pH 
7.4,15 mM magnesium acetate). 
Aminoacvlarion Plateau Charging Assay 
tRNA concentration was determined by a plateau charging assay. Plateau levels of 
aminoacylation of purified tRNA transcripts with valine were determined at 37°C in a 60 |il 
reaction mixture containing 100 mM HEPES (pH 7.5), 10 mM KCl, 15 mM MgCb, 7 mM 
ATP, ImM DTT, 99 (iM [^H] valine, 0.05 to 0.1 A260 of purified tRNAs, and an excess 
amount of ValRS (0.04 jig/^il). Ten pJ aliquots were taken at different incubation times up to 
60 minutes and spotted onto Whatman 3 MM filter paper which had been pre-soaked with 
10% trichloroacetic acid (TCA) to stop the reaction. The paper was washed 3 times with 
cold 5% TCA and two times with cold 95% ethanol. After being dried, radioactivity on the 
paper was determined by liquid scintillation counting in Biosafe NA scintillation fluor. 
Plateau levels of charging tRNA'^^ transcripts with alanine were determined at 37°C, 
in a 60 |il reaction mixture containing 150 mM potassium phosphate (pH 7.5), 10 mM 
MgCb, 20 mM DTT, 4 mM ATP, 0.1 mg/ml BSA, 4 units of pyrophosphatase, 43 ^iM [^H] 
alanine, and purified alanyl-tRNA synthetase (Park et al.^ 1989). Ten nl aliquots were taken 
at different time points and spotted on Whatman 3 MM filter paper. The filter paper was 
processed as described for aminoacylation with valine. 
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Plateau levels of charging tRNA^ with phenylalanine were determine at 37°C, in a 
60 nl reaction mixture containing 30 mM HEPES (pH 7.5), 2 mM ATP, 25 mM KCl, 15 mM 
MgCb, 4 mM DTT and 25 (jM [^H] phenylalanine, and 0.04 ng/|il partially purified 
phenylalanyl-tRNA synthetase (Peterson and Uhlenbeck, 1992). Ten |il aliquots were taken 
at different time points and spotted on Whatman 3 MM filter paper. The filter paper was 
processed as described for aminoacylation with valine. 
Aminoacvlation Kinetics of tRNA Variants 
Aminoacylation kinetic experiments were carried out at 37°C, in a 60 (xl reaction 
mixture containing 100 mM HEPES pH 7.5, 10 mM KCl, 15 mM MgCU, 7 mM ATP, ImM 
DTT, 99 |iM [^H] valine, and InM purified ValRS. tRNA concentrations normally ranged 
fi"om 0.5 |iM to 6.0 ^iM as determined by the plateau charging assay. Ten jil were removed 
at 30-second intervals, spotted on Whatman 3 MM paper, and processed as described for the 
aminoacylation plateau charging assay. Initial velocities were obtained at five different 
concentrations of tRNA. Kn and Vma values were determined by a least-square fit of the 
double-reciprocal plot of the data using the Enzfitter computer program. The results 
reported are the average of two or more determinations which agreed within ±15%. 
Isolation of Aminoacvl-tRNAs 
Aminoacylation of HPLC purified E. coli tRNA^**, tRNA'^" or tRNA"" variants was 
carried out at 37°C as described under aminoacylation plateau charging assay for the 
respective tRNAs. When the plateau charging level of aminoacylation was reached, as 
determined by taking small aliquot of sample for analysis, the reaction was stopped by 
addition of an equal volume of phenol/choroformAsoamyl alcohol (25:24; 1). The mixture 
was then extracted once with chloroform/isoamyl alcohol (24; I). Aminoacylated tRNA was 
precipitated with ethanol, and the pellet washed with 70% ethanol, dried, and dissolved in a 
small volume of 5 mM potassium acetate, pH 5.4. The sample was then loaded onto a 
column of Sephadex G-25 (coarse grade, Pharmacia, Inc.) that had previously been 
equilibrated with the same buffer. Elution with the same buffer yielded aminoacyl-tRNA 
freed of low molecular weight contaminants including radioactive valine. The eluted 
aminoacyl-tRNA was recovered by ethanol precipitation, followed by washing once with 
70% ethanol, and was dissolved in 5 mM potassium acetate, pH 5.4. 
Purification of Tight-Coupled E. coli 70S Ribosome 
This purification procedure was based on the method of Pestka and Erbe (Pestka, 
1968; Erbe et ai, 1969). E. coli BL21 (DE3) was grown at 37°C to mid-log phase and 
collected by centrifligation. From this point on, all steps in the procedure were performed at 
4°C. The collected cells were washed with buffer A; 20 mM HEPES (pH 7.5), 10.5 mM 
Mg(0Ac)2, 0.5 mM EDTA, 60 mM NH4CI, and 10 mM 3-mercaptoethanol. The washed 
cells (8 grams) were again collected by centrifugation and resuspended in 20 ml buffer A. 
The cells were broken by three passes through a French Pressure cell. A 25 |il aliquot of 
diethylpyrocarbonate was added to inhibit ribonuclease activity. The cell paste was 
centrifuged at 17.5 K rpm in a JA20 rotor for one hour. The top 2/3 of the supernatant was 
removed and carefully layered onto an equal volume of sucrose cushion; 20 mM HEPES 
(pH 7.5), 10.5 mM Mg(0Ac)2, 0.5 mM EDTA, 0.5 M NH4CI, 10 mM P-mercaptoethanol, 
and 1.1 M sucrose. Ribosomes were pelleted by centrifugation at 40 K rpm for 14 hours in a 
Beckman Ti 70 rotor. Purified 70S ribosomes were obtained by washing the crude ribosomes 
three times with 1.0 M NH4CI. The ribosome pellet was resuspended in 10 mM Tris-HCI 
(pH 7.8), 10 mM MgCh, 1 mM P-mercaptoethanol, and 1.0 M NH4CI, and shaken gently for 
12 hours. NH4CI washed ribosomes were pelleted by centrifiigation at 40 K rpm for three 
hours. The NH4CI washing procedure was repeated twice. The final ribosome pellet was 
suspended in a buffer containing 10 mM Tris-HCI (pH 7.5), 10 mM Mg(OAc)2, 60 mM 
NH4CI, and 3 mM P-mercaptoethanol. The final A260/A280 ratio was determined to be 2.0. 
In vitro PoIydJvGVDirected (VaK Phe> Polypeptide Synthesis 
The in vitro polypeptide synthesis reaction was based on the procedure of Ofengand 
et al. (1974). The reaction was carried out in a 100 |il reaction mixture containing 50 mM 
Bicine (pH 7.5), 50 mM NH4CI, 20 mM Mg(0Ac)2, 3 mM ATP, 1 mM DTT, 1 mM GTP, 10 
mM phosphoenol pyruvate (PEP), 0.05 mM unlabeled valine, 0.05 mM unlabeled 
phenylalanine, 154 pmol of£. coli tRNA^°, 90 pmol of [^H]valyl-tRNA^*', 40 ng E. coli S-
100, 32 }ig of poly(U3,G), 4 units pyruvate kinase, 3.7 A260 units of NH4CI washed 
ribosomes. Reactions were initiated by addition of 70S ribosomes (ribosomes were pre-
incubated at 37°C for 30 nunutes), and the reaction mixture was incubated at 37°C for the 
indicated time intervals. The reaction was stopped by adding 5% TCA, and the mixture was 
heated at 95°C for 20 minutes. After samples had cooled on ice for 20 minutes, the TCA 
precipitates were collected on Millipore filters (Millipore Corp.), and washed four times with 
cold 5% TCA and once with cold 95% ethanol. Filters were dried and the radioactivity was 
determined by liquid scintillation counting in BioSafe NA scintillation fluor. 
Purification of Elongation Factor Tu 
E. coli JM109 was transformed with pQECtuf containing the gene for T. 
thermophilus elongation factor Tu. The purification procedure was a simple one-column step 
utilizing the presence of a His-tag at the C-terminus of the protein (Ribeu-o et al., 1995). A 
500 ml culture at 37°C was grown to mid-log phase, induced by adding 1 mM IPTG, and 
allowed to grow for five more hours. Cells were collected by centrifijgation and resuspended 
in 10 ml of lysis buflfer; 50 mM Tris-HCl (pH 7.5), 10 mM MgCla, 0.5 mM DTT, 10 |iM 
PMSF, 1 mM sodium azide, 40 |il of 0.25 M EDTA. Five mg of lysozyme were then added, 
and the solution was stirred on a magnetic stir-plate for 10 minutes. 200 jil of 4% sodium 
deoxycholate and 20 ^il of 10 mg/ml DNase I were added, and the solution was again stirred 
for a short time and then left at room temperature for 20 minutes. Cell debris was collected 
by centrifiigation at 30,000x g for 30 minutes, and the supernatant was subject to 
centrifiigation at 100,000x g for 3 hours. The clear supernatant was dialyzed against buffer 
A: 20 mM potassium phosphate (pH 7.5), 500 mM KCl. The dialyzed sample was loaded on 
a Ni-NTA Superflow nickel column (Qiagen Inc.) equilibrated with buffer A at a flow rate of 
0.5 ml/min. Following loading of the sample, the column was washed with two column 
volumes of buffer B containing; 20 mM potassium phosphate (pH 6.2), 500 mM KCl. EF-
Tu was then eluted with a linear gradient of 0 to 500 mM imidazole in buffer B in 10 column 
volumes. 2.5 ml fi'actions were collected, and their A2go values measured. Purified 
elongation factor Tu was homogeneous as determined by eletrophoresis on 10% SDS-
polyacrylamide gel electrophoresis (PAGE) (Laemmli, 1970). Proteins were visualized by 
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staining the gels with 1% Coomassie Brilliant Blue G-250 in 40% methanol and 10% acetic 
acid. 
Purification of £1 coH Phenvlalanvi-tRNA Synthetase 
E. coli phenylalanyl-tRNA synthetase (PheRS) was partially purified fi-om E. coli 
JM109 based on the procedure of Peterson and Uhlenbeck (Peterson and Uhlenbeck, 1992) 
fi-om the 35% ammonium sulfate precipitate obtained in the course of preparing ValRS (Chu 
and Horowitz, 1991). The ammonium sulfate precipitate was resuspended in sample buffer 
containing 50 mM Tris-HCI (pH 8.0), 1 mM EDTA 10% glycerol, and 5 mM P-
mercaptoethanol, and dialyzed extensively against the same buflfer. A white precipitate 
formed in the dialysis tube. The supernatant containing PheRS activity was further dialyzed 
against the same buffer, and then chromatographed on a Mono Q HR 10/10 column 
(Pharmacia) using the FPLC system. The column was equilibrated in sample buffer 
containing 40 mM KCl. After loading the dialyzed sample, proteins were eluted with a 200 
ml linear gradient of KCI from 40 mM to 400 mM. PheRS activity eluted between 200 mM 
and 250 mM KCI. 
Determination of Ternary Complex Formation by Hydrolysis Protection Assay 
Interaction of EF-Tu:GTP with aminoacyl-tRNA protects the labile aminoacyl ester 
bond from spontaneous hydrolysis (Pingoud et al., 1977). Hydrolysis protection assays were 
performed at 37®C in a 160 nl reaction mixture containing 50 mM Tris-HCI (pH 8.0), 50 mM 
KCI, 10 mM MgCl2, 0.3 loM [^H] aminoacyl-tRNA, and 3 ^iM EF-Tu:GTP. The pH of the 
reaction was chosen because it allowed a significant spontaneous hydrolysis to occur in a 
reasonable amount of time. The reaction was initiated by the addition of [^H] aminoacyl-
tRNA. 20 aliquots were removed at the indicated time intervals and spotted on TC A-
presoaked Whatman 3 MM fiher paper. Filter papers were process as described for the 
aminoacylation plateau charging assay, and radioactivity was determined by liquid 
scintillation counting in BioSafe NA scintillation fluor. EF-Tu;GDP was first activated to 
EF-Tu:GTP by incubation of 40 |iM EF-Tu:GDP at 37°C for three hours in 50 mM Tris-HCl 
(pH8.0), 10 mM MgClz, 50 mM KCl, 440 ^M GTP, 6 mM PEP, 5 mM DTT, 1 unit/^l 
pyruvate kinase. 
Ribonuclease Protection Assay to Determine Dissociation Constants of Ternary 
Complexes 
Dissociation constants of EF-Tu:GTP:valyl -tRNA^'' ternary complexese were 
determined by a RNase protection assay based on the method of Louie and Jumak (1985). 
The principle of the assay involves allowing formation of a ternary complex between [^H] 
valyl -tRNA^*' and EF-Tu:GTP. Uncomplexed [^H] valyl-tRNA^** is digested by brief 
exposure to pancreatic ribonuclease A, and [^H] valyl-tRNA^"* associated in a ternary 
complex is determined by measuring radioactivity that remains TCA precipitable. The assay 
was performed at two concentrations of [^H] valyl -tRNA^ ®' and seven concentrations of EF-
Tu:GTP. Reactions were carried out in 100 nl mixture containing 50 mM Tris-HCl (pH 7.5), 
10 mM MgCl2, 150 mM NHjCl, 5 mM DTT, 3 mM PEP, 20 }jM GTP, 50 units/ml pyruvate 
kinase, and the indicated amount of [^H] valyl -tRNA^"* and EF-Tu.GTP. EF-Tu;GDP was 
activated to EF-Tu:GTP as described for the hydrolysis protection assay. Each reaction 
mixture was incubated on ice for 15 minutes and then treated with 5 |il of 2 mg/ml pancreatic 
ribonuclease A (Sigma) for 15 seconds. Ribonuclease digestion was stopped by rapid 
addition of 50 nl of Img/ml bulk yeast RNA (Sigma) and 200 nl of cold 10% TCA. 
Precipitates were collected on Millipore filters, washed three times with 10% TCA dried, 
and counted by liquid scintillation counting in BioSafe NA scintillation fluor. The 
dissociation constant is obtained by employing this equation; 
Kd = [uncomplexed EF-Tu:GTP][uncomplexed [^H] valyl-tRNA^*']/[EF-Tu;GTP: [^H] 
valyl-tRNA"""]. 
In order to obtain an accurate IQ value, it is essential to determine precisely the 
concentration of EF-Tu;GTP and valyl-tRNA^"* in the reaction. The concentration of EF-
Tu.GTP was determined by titrating a fixed amount of EF-Tu:GTP with increasing amounts 
of valyl-tRNA^** (Figure 4). In the experiment shown, the fixed amount of EF-Tu.GTP was 
10 pmol based on the Bradford assay (Bradford, 1976), and the amount of valyl-tRNA^** 
protected reached a plateau level at 4 pmol. Assuming a 1; 1 EF-Tu:GTP/valyl-tRNA^^ 
complex, 40% of the EF-Tu:GTP in the reaction was active in ternary complex formation. 
Typically, the active concentration of EF-Tu;GTP was between 35 to 45% of added EF-
Tu.GTP. To determine the active valyl-tRNA^** concentration, a similar approach was 
taken. A fixed amount of valyl-tRNA^** was titrated with increasing amount of EF-Tu:GTP 
(Figure 5). In this experiment, the amount of wild type valyl-tRNA^'** was fixed at 7 pmol, 
and the amount protected at high EF-Tu.GTP concentrations reached a plateau of 6 pmol. 
Therefore, about 86% of the valyl-tRNA^*" was active in ternary complex formation. 
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pmoie of valyl-tRNA^"' added 
Figure 4. Determination of active [EF-Tu;GTP] in the ribonuclease protection assay. 
EF-Tu;GTP concentration is fixed at 10 pmole. 
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pmole of EF-Tu:GTP added 
Figure 5. Determination of active [valyl-tRNA^"'] in the ribonuclease protection assay. 
Valyl-tRNA^"' concentration is fixed at 7 pmole. 
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RESULTS 
Search for the Complete Identity Elements in £1 colL tRNA^** 
Two different approaches were used to search for the complete identity elements in E. 
coli tRNA^"*. First, the aminoacylation efficiency of in vitro transcribed tRNA^** variants, 
obtained by introducing specific nucleotide changes into wild-type tRNA^*", was determined. 
When the catalytic efficiency for a tRNA^** variant is significantly reduced, it can be 
attributed to the absence of recognition nucleotide(s) in that tRNA. With this approach, our 
laboratory has identified several identity elements in E. coli tRNA^*' (Chu et al. 1992; Liu, 
1995). Second, identity swap experiments were carried out to identify positive identity 
elements essential for ValRS recognition and negative identity elements which prevent proper 
recognition by ValRS. In these experiments, identity determinants of tRNA^"* were 
introduced into the sequence fi-amework of another tRNA, and the chimeric tRNA was tested 
for the efficiency of its aminoacylation with valine. Liu (1995) has successfiilly converted E. 
coli tRNA'^'CUGC) to an efficient substrate for ValRS. Building on the success of these 
experiments, the goal of this study is to understand all the determinants that govern the 
specific and efficient recognition of E. coli tRNA^** by ValRS. 
Kinetic Study of E. coli tRNA^** Variants 
It was previously found in our laboratory and others that anticodon positions A3 5 and 
C36 are the major positive synthetase recognition determinants of tRNA^*' (Schulman and 
Pelka, 1988; Tamura et al., 1991; Chu et al., 1992). Any mutation introduced into these two 
positions either completely abolishes or greatly reduces the aminoacylation activity of 
tRNA^"'variants. In addition, the discriminator base A73 (Liu, 1995; Tamurae/a/., 1991) 
and position G20 (Liu, 1995) in the D-loop were identified as recognition nucleotides of 
tRNA^'". 
Aminoacylation kinetic studies of tRNA^"* variants were carried out to identify 
additional determinants essential for valyl-tRNA synthetase (ValRS) recognition of the 
tRNA, and to detect negative determinants which prevent proper/eflBcient recognition by 
ValRS. These studies help us to understand the complexity of tRNA-synthetase interactions 
and how the high specificity of aminoacylation is achieved. 
E. coli tRNA^** variants in the acceptor stem 
The acceptor stem contains major recognition nucleotides for some tRNAs (Hou and 
Schimmel, 1988; McClain and Foss, 1988; Jahn et al, 1991; Liu et ai, 1995). The premier 
example is tRNA'^*. Its identity element has been found to reside almost exclusively in a 
single G3:U70 base pair by both in vivo (McClain and Foss, 1988) and in vitro (Hou and 
Schimmel, 1988) experiments. Tamura and coworkers reported that changing the base pair 
U4:A69 to A4:U69 in tRNA^'' decreases the aminoacylation activity of tRNA^*® by 5.3-fold, 
and substitution of G3:C70 with C3;G70 reduces the activity of tRNA^*' by 2.3-fold (Tamura 
et al., 1991). They concluded that both the U4:A69 and the G3:C70 base pairs are identity 
elements of tRNA^*". Results firom our laboratory contradict these conclusions (Liu, 1995). 
Liu (1995) found that the same mutations do not reduce the aminoacylation activity of the 
tRNA^** significantly; the C4:G69 variant of tRNA^*' was also a good substrate for ValRS 
(Vahid Feiz, unpublished results). To complete the set of Watson Crick base pair 
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Table 1. Kinetic parameters for aminoacylation of tRNA^** variants at position 4:69 in the 
acceptor stem 
Val tRNA 
Variants 
Wild type 
tRNA"^" 
K„, 
(HM) 
1.4 
loi/min/mfi 
5.0 
VnuEi/Kni 
3.6 
Relative 
(Vto/Kto) 
(1.0) 
U4:A69 -> 
G4;C69 
6.2 6.8 1.1 0.31 
U4:A69 -> 
G4:U69 
20.0 1.9 0.095 0.026 
U4:A69 
U4.G69 
10.4 6.2 0.60 0.17 
U4:A69 
U4*C69 
2.9 5.8 2.0 0.56 
U4;A69 -> 
A4*G69 
8.9 6.1 0.69 0.19 
A6;U67 
G6:U67 
3.2 5.9 1.8 0.50 
U7;A66 -> 
U7:G66 
4.1 7.2 1.8 0.50 
substitutions at position 4:69, G4:C69 was constructed. Both and Vmax are increased by 
4.4-fold and 1.4-fold, respectively, resulting in a 3.2-fold decrease in the catalytic efficiency 
(Table 1). Introduction of G4:C69 into the acceptor stem of tRNA^*" convert the first five 
base pairs into a series of consecutive G:C base pairs (Figure 2), and this may contribute to 
the lower activity of this mutant (see Discussion). Thus Watson-Crick base pair substitutions 
at position 4:69 of E. coli tRNA^** have little effect on the aminoacylation activity of 
tRNA"'*'. 
Watson-Crick base pair substitutions at other positions in the acceptor stem helix also 
do not significantly affect aminoacylation (Liu, 1995). However, introduction of G;U wobble 
base pair substitutions in the first three base pairs of the acceptor stem helix lead to a gradual 
decrease in activity as the site of mutation moves closer to position 4:69 (Liu, 1995). To 
further investigate the effects of G:U base pairs in the acceptor helix of tRNA^*^ on 
aminoacylation activity, G. U base pairs were introduced into the bottom half of the acceptor 
stem (4:69,6:67, and 7:66). Introduction of wobble base pairs G4:U69 or U4:G69 results in 
a large reduction, 38 and 6-fold respectively, ui (Table 1). Loss of activity is due 
mamly to a large increase in K,„ in these two wobble base pair variants of tRNA^"*. A 
significant decrease in Vmax is also observed for the G4:U69 variant. Wobble base pair (G:U) 
substitutions into position 6:67 or 7:66, the last two base pairs of the acceptor stem, have 
only moderate effects on the catalytic efficiency of tRNA^** (Table 1). 
Two additional non-canonical base pairs, U:C and A:G, were introduced at position 
4:69. The U4:C69 mutant tRNA has decent activity, 56% that of the wild type tRNA (Table 
1). Aminoacylation activity of the A4:G69 tRNA^"' variant is considerably lower, 19% of 
wild type activity (Table 1). These results indicate that a pyrimidine:pyrimidine mismatch is 
tolerated better than a purine:purine mismatch (see Discussion). 
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Effect of acceptor stem variants of tRNA^** on the afSnitv for valine in aminoacylation 
Recently, Soli and coworkers showed that for some aminoacyl-tRNA synthetases 
interaction with identity determinants in tRNA affects the amino acid aflSnity of the enzyme, 
and this may influence identification of synthetase recognition determinants in the tRNA (Ibba 
et ai, 1996; Hong et ai, 1996). Recognition determinants ofE. coli tRNA®*" were first 
identified by aminoacylation kinetic studies carried out at sub-optimal amino acid 
concentration (Jahn etal., 1991). Several of these were later reclassified when optimal 
amino acid concentrations were used. 
Steady-state kinetic studies were conducted with wild type E. coli tRNA^** and with 
several acceptor stem variants to investigate the effects of base substitutions on the affinity of 
ValRS for valine in the aminoacylation reaction. Michaelis constants (Km) for valine in the 
aminoacylation reaction were determined. The Km value for valine in the reaction with wild 
type tRNA^®* is 42.8 (iM (Table 2); this value is similar to the value of 45 |iM previously 
determined (Chu and Horowitz, unpublished). The VmK for this reaction was found to be 
6.50 |imol/min/mg, which is slightly higher than the VmK value of 5.0 reported for wild type 
tRNA^*' in Table I. In aminoacylation of the A4;U69 tRNA^*" variant, K® and Vmax values of 
45.9 and 5.84, respectively, were determined (Table 2). Both values are comparable to those 
of the reaction with wild type tRNA^ *'. The Km and values observed with C3:G70 
tRNA^"' are slightly higher than those with wild type tRNA (Table 2). Overall, wild type 
tRNA^*' and the two tRNA^*" variants in the acceptor stem have comparable Vnux/Km values. 
These results suggest that at least several mutations in the acceptor stem of tRNA^'' do not 
influence the valine affinity of ValRS. 
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Table 2. Kinetic parameters for aminoacylation of tRNA^** variants in the acceptor stem; 
Determination of Km for valine 
tRNA Km(uM) 
Variants (vaune 
Vmax 
timol/min/mg) 
Wild type 
tRNA^" 
42.8 6.50 
Vnucc/Km 
0.15 
Relative 
(1.0) 
U4;A69 
A4;U69 
45.9 5.84 0.13 0.87 
G3;C70 
C3:G70 
59.8 7.18 0.12 0.80 
The kinetic parameters for aminoacylation of tRNA^®* variants were previously 
determined at valine concentration of 100 (iM (about 2 times the Km for valine in the reaction 
with wild type tRNA^*' and the two acceptor stem variants). Kinetic parameters for 
aminoacylation of tRNA^®' variants were also measured at valine concentrations of 10 |iM, 
below their BCm (sub-optimal concentration), to determine whether mutations in the acceptor 
stem and discriminator base (position 73) affect the substrate efficiency of tRNA^ "^ under 
these conditions. Wild type tRNA'"®' has Km and Vnua values of 0.79 and 1.19, respectively, 
at 10 |iM valine (Table 3). Km and Vmax for the A4:U69 variant are very close to those for 
wild type tRNA^ *'; it has a catalytic efficiency 83% that of the wild-type (Table 3). The 
C3 .G70 tRNA^*" variant has slightly elevated Km and Vnu.x values that result in a relative 
catalytic efficiency of 72%. These results agree well with our previous results, obtained at 
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Table 3. BCinetic parameters for aminoacylation of tRNA^** variants in the acceptor stem 
under sub-optimal valine concentration (10 piM) 
Val tRNA 
Variants 
Wild type 
tRNA''" 
U4;A69 ^ 
A4;U69 
G3:C70 
C3:G70 
A73 -> C73 
A73 -> U73 
KnCuM) V„^ 
(tRNA) (tmiol/min/mg) 
0.79 
0.77 
1.27 
0.74 
1.46 
1.19 
0.97 
1.37 
0.71 
0.90 
1.51 
1.26 
1.08 
0.96 
0.62 
Relative 
(Vmax/K^) 
(1.0) 
0.83 
0.72 
0.64 
0.41 
A73 -> G73 0.011 0.007 
100 nM valine, that showed A4:U69 and C3:G70 variants having 86% and 81% of wild type 
tRNA^** aminoacylation activity (Liu, 1995) and indicate that U4;A69 and G3:C70 are not 
identity elements in tRNA^" for recognition by ValRS or for specific valine recognition. 
Similar experiments were carried out with tRNA^"^ having nucleotide substitutions at 
position 73. The discriminator base, A73, of tRNA^"' was previously found to be an identity 
element because substitution by G reduces activity in the aminoacylation reaction 38-fold at 
100 jiM valine (Liu, 1995); the U73 and C73 variants are, respectively, 31% and 44% as 
active as wild-type tRNA^*' (A73). Substitution of A73 with either C73 or U73 results in 
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tRNA^** variants that have a moderate decrease in activity at 10 ^iM valine (Table 3). The 
C73 tRNA^*" variant is 64% as active as wild type (Table 3); the decrease is due entirely to a 
1.7 fold decrease in V^ix For the U73 tRNA^*" variant, the activity loss comes from a 1.8 
fold increase in K,n and a 1.3 fold decrease in Vnu*; its activity is 41% that of wild-type 
jrNa^'®i (Table 3). The activity of the G73 tRNA^*" variant is lower than that of wild-type 
tRNA^"* by two orders of magnitude (Table 3). The individual and Vma values were not 
determined due to the low activity. Values for the relative specificity constants agree well 
with our previous results, obtained at 100 pM valine. 
Mutation of nucleotides involved in tertiary interactions 
The role of tertiary interactions in maintaining the native folding of tRNAs is well 
established. Recently, studies with some tRNAs have identified bases involved in tertiary 
interactions as recognition nucleotides (Liu et ai, 1995; Peterson and Uhlenbeck, 1992). In 
this section, the role of several tertiary interactions in the recognition of tRNA^*' by ValRS is 
investigated further. The following studies focus on positions 26, 44, and 45 of E. coli 
tRNA'*'. 
In the crystal structure of yeast tRNA*^ bases 26 and 44 form a purine-purine base 
pair at the junction of the anticodon and D stems. This base pair is stacked on both stems, 
and is responsible for a 26° kink between these two helices (Kim, 1976). An adenine (A) or 
guanine (G) occurs at position 26 in 95% of E. coli tRNAs. Therefore, A26 was first 
substituted with G26; and the result indicates that the V,nax/K„i of the G26 tRNA^ '' variant is 
45% that of wild type tRNA^'' (Table 4). A base change at position 44 results in a slightly 
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Table 4. Kinetic parameters for aminoacylation of tRNA^** variants involved in tertiary 
interaction 
tRNA^'" 
Variants 
Wild tj^e 
tRNA^" 
A26 -» G26 
G44 A44 
A26-G44 -> 
G26-A44 
G45 A45 
G45 U45 
1.4 
3.6 
3.5 
1.9 
3.8 
2.7 
(limol/min/mg) 
5.0 
5.8 
4.4 
7.1 
6.6 
5.5 
Vnuo/Koi 
3.6 
1.6 
1.3 
3.7 
1.7 
2.1 
Relative 
(1.0) 
0.45 
0.36 
1.04 
0.48 
0.57 
greater reduction of aminoacylation activity to 36% that of the wild-type (Table 4) . In both 
cases, the loss of aminoacylation activity is due largely to an increase in Km by about 2.5-fold. 
A double mutant was constructed by replacing A26 with G26 and G44 with A44. These 
substitutions recapitulate the A;G tertiary base pair, although the locations of the bases are 
interchanged. This double mutant, G26:A44 tRNA^*", is as good a substrate for valyl-tRNA 
synthetase as wild type tRNA^"^ (Table 4). 
Position 45 is involved in a tertiary interaction with base pair 10:25 in the D-stem (see 
Figure 1 A). Substitution of G45 by A, reduces the specificity constant (Vmax/Km) of the 
tRNA^^ variant 2.1-fold compared to wild type tRNA^** (Table 4). Replacement of G45 by 
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U45 reduces the specificity constant 1.8-fold (Table 4). In both tRNA^** variants, the Vma 
remains relatively unchanged compared to that of wild type tRNA^"*; the reduction in the 
specificity constant is due mainly to an increase in Km. 
Identity Swap Eiperiments 
The accuracy of aminoacylation reactions depend not only on the efficient and 
productive interaction of a tRNA molecule with its cognate aminoacyl-tRNA synthetase, but 
also on how the synthetase discriminates against noncognate tRNA molecules. To further 
investigate the structural requirements for the recognition of E. coli tRNA^®* by ValRS, and 
to uncover possible negative determinants and/or additional recognition nucleotides, identity 
swap experiments were carried out by transplanting the known recognition elements of 
tRNA^*' into yeast tRNA"" and E. coli tRNA^. 
Conversion of veast tRNA"" to a valine acceptor 
Nucleotide substitution mE.  co l i  tRNA^"* had shown that A35, C36, A73 and to a 
lesser extent G20 are recognition determinants for ValRS. If this set of synthetase 
recognition nucleotides in tRNA^*' is complete, then it is reasonable to postulate that 
introduction of these four recognition nucleotides into noncognate tRNA molecules will 
convert them to valine accepting species. Figure 4 compares the sequence of E. coli tRNA^"' 
and yeast tRNA*^. Yeast tRNA'^ differs from tRNA^*' at 28 positions (shown boxed in 
Figure 6), most of which are located in the acceptor stem, anticodon stem and loop, and T-
stem. Yeast tRNA'^has three of the four identified tRNA^'^ recognition nucleotides; only 
position 36 differs, tRNA'^ has A in place of the C36 in tRNA^*'. The recognition model 
predicts that changing A3 6 of yeast tRNA^° to C36 should result in an efficient substrate for 
Figure 6. Comparison of the nucleotide sequences of E. coli tRNA^*' (UAC anticodon) and yeast tRNA*^' (GAA anticodon). 
Shaded regions indicate sequence differences between the two tRNAs. 
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ValRS. 
Wild type yeast tRNA""(GAA) is a very poor substrate for ValRS. Its level of 
aminoacylation with valine is almost undetectable, its specificity constant is at least five 
orders of magnitude lower than that for wild type E. coli tRNA^** (Table 5). Because C36 
a major identity element for tRNA^*', substitution of A36 with C36 in yeast tRNA^, as 
expeaed, markedly increases the valine accepting eflSciency of yeast tRNA'^ (Table 5). 
However, this yeast tRNA^(GAC) variant still has only 14% of the wild type tRNA^"* 
activity. 
Table 5. Kinetic parameters for aminoacylation of yeast tRNA'^' variants with valine 
Val tRNA 
Variants 
Kn.(nM) Vmax/Kni Relative 
(Vmax/K„ 
Wild t^e 
tRNA^'"' 
1.4 5.0 3.6 (1.0) 
tRNA""=(GAA) 3.9x10 RS l . I x I O  -5 
tRNA^'^(GAC) 3.3 1.7 0.52 0.14 
tRNA'''"(GAC) 
A4 
2.1 4.15 2.0 0.56 
tRNA^'''(GAA) 
A4 
1.3x10"' 3.6x10-' 
Previous experiments showed that a G4:U69 wobble base pair in the acceptor stem of 
tRNA^"* reduces the valine accepting activity of the tRNA considerably (Table 1). The G:U 
pair at position 4 :69 in the acceptor stem of yeast tRNA"^ could be the reason that yeast 
tRNA"*(GAC), which has all the recognition nucleotides of tRNA^**, is a poor substrate for 
ValRS. 
When the G4;U69 base pair of yeast tRNA^(GAC) is converted to an A4;U69 
Watson-Crick base pair by mutation of G4 to A4, the aminoacylation activity of the resulting 
tRNA increases considerably. This tRNA*^ variant has a relative Vmax/Km of 0.56 compared 
to that of wild type tRNA^** (Table 5). Changing G4:U69 to A4:U69 alone, in the absence of 
the A3 6 to C3 6 change, allows yeast tRNA^ to accept valine slightly better than wild type 
yeast tRNA^, but its relative Vnuw/Km is still almost five orders of magnitude lower than that 
of tRNA^"^ (Table 5). These results show that two nucleotide changes in yeast tRNA^: 
A36 to C36 and elimination of the G:U wobble base pair in the acceptor stem, convert the 
tRNA into a good valine acceptor. 
Conversion of E. coli tRNA"* to a valine acceptor 
A similar identity swap experiment was carried out with E. coli tRNA®'''® to examine 
the effects of the known recognition determinants in another tRNA sequence framework. 
The sequence of E. coli tRNA^° differs from that of E. coli tRNA^^ at 32 positions, 
including most of the acceptor stem, the entire anticodon stem, part of the anticodon loop 
and part of the T-stem (Figure 7). E. coli tRNA"*® has two of the four tRNA^®* recognition 
nucleotides, A35 and A73, but has A36 m place of C36 and U20 instead of G20. The 
Figure 7. Comparison of the nucleotide sequences of E. coli tRNA^*' (UAC anticodon) and E. coli tRNA"" (GAA anticodon). 
Shaded regions indicate sequence differences between the two tRNAs. 
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recognition model predicts that changing U20 and A36 o fE .  co l i  tRNA*^ to G20 and C36 
should result in an efficient substrate for ValRS. 
Wild type E. coli tRNA'^(GAA) is not a substrate for ValRS (Table 6). Substitution 
of U20 and A36 in E. coli tRNA^ with G20 and C36 allows this variant to accept valine at 
a low level (see also Liu, 1995). The catalytic efficiency of this tRNA^ variant is only 1% 
Table 6. Kinetic parameters for aminoacylation of acceptor stem and variable loop mutants 
E. coli tRNA"~ with valine 
tRNA^"* 
Variants 
Wild type 
K„,(^iM) 
tRNA^'" 
tRNA""(GAA) 
tElNA^'(GAC) 
G20 
tRNA^'"(GAC) 
G20 M3" 
tRNA^'"(GAC) 
G20M3 A6.U67 
tRNA^'^(GAC) 
G20M3 G6;U67 
tRNA^'"(GAC) 
G20 G45 
tRNA^'(GAC) 
G20 M3 G45 
1.4 
V„^ 
lol/min/m.E 
5.0 
VnuLx/Km Relative 
(Vn^,/K„) 
No Detectable Aminoacylation 
17.1 0.58 
14.7 
7.2 
l l . O  
23.3 
8.0 
3.4 
3.4 
2.1 
2.1 
5.0 
3.6 
0.03 
0.23 
0,47 
0.19 
0.09 
0.63 
(1.0) 
0.01 
0.06 
0.13 
0.05 
0.03 
0.18 
M3 represents the three base pair mutations of C27:G43. C28;G42, and U29;A41. 
that of wild type tRNA^ ** (Table 6). Additional mutations were introduced into this tRNA to 
improve its efBciency as a substrate for ValRS and to identify additional positive and/or 
negative recognition nucleotides. 
tRNA'''" variants in the acceptor stem 
The acceptor stem of wild type tRNA"^(GAA) is very rich in G:C base pairs in its 
(Figure 7); six of the seven base pairs are G:C/C;G base pairs. The aminoacylation of 
tRNA^ variants with valine may be affected by the G;C-rich acceptor stem helix. To 
decrease the number of G:C base pairs in the acceptor stem helix, the G6:C67 base pair of E. 
coli tRNA^(GAC) G20 was mutated by making a single base substitution that changes base 
pair G6:C67 to G6;U67, and a two-base substitution that changes base pair G6:C67 to 
A6:U67. The velocity of aminoacylation of these tRNA^ variants is shown on Figure 8. 
The double mutant has an aminoacylation rate that is slightly higher than tRNA"" variants 
without the mutation, while the base substitution that introduces a G:U base pair into the 
acceptor stem causes a small but consistent decrease in the rate of aminoacylation. The same 
mutations at base pair 6:67 were also introduced into a variant of E. coli tRNA^'(GAC) 
G20, tRNA^(GAC) G20 M3, which has the top three base pairs of the anticodon stem 
converted to those found in E. coli tRNA^"*. Introduction of the M3 mutation into E. coli 
tRNA""(GAC) G20 interrupts a series of G;C base pairs in the anticodon stem (Figure 7), 
but does not significantly improve aminoacylation with valine (Table 6). The time course of 
aminoacylation of the two tRNA'^'(GAC) G20 M3 variants with mutations at positions 6 and 
67 (Figure 9) gave results similar to those found with the same mutations in the framework of 
tRNA""'(GAC) G20 (Figure 8). The kinetic parameters for aminoacylation of 
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Figure 8. Time course of aminoacylation with valine of wild type tRNA^ "', 
tRNA'^(GAC)G20 A6;U67 (open triangles), tRNA'''"(GAC)G20 (open circles), 
and tRNA^°(GAC)G20 U67 (closed triangles). ValRS and tRNA concentrations 
are 0.1 ng/|il and 2 laM, respectively. 
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Figure 9. Time course of aminoacylation with valine of wild type tRNA^"' (closed circles), 
tRNA^''=(GAC)G20 M3 A6:U67 (open triangles), tRNA"''(GAC)G20 M3 (open 
circles), and tRNA'''"(GAC)G20 M3 U67 (closed triangles). ValRS and tRNA 
concentrations are 0.1 ng/jil and 2 (iM, respectively. 
tRNA'^(GAC) G20 M3 variants with base substitutions at position 6 and 67 are shown in 
Table 6. For the double mutant tRNA^(GAC) G20 M3 A6:U67, Km is reduced 2 fold 
compared to tRNA'^(GAC) G20 M3 while Vm.v stays the same (Table 6). For 
tRNA""(GAC) G20 M3 U67, the presence of a G;U base pair in the acceptor stem sUghtly 
reduces its aminoacylation activity (Table 6). Substitution of A6:U67 with G6;U67 in 
tRNA^"' also causes a 2-fold decrease in activity (Table 1). 
To disrupt the series of G;C base pairs in the acceptor stem helix, two additional 
acceptor stem mutants in the framework of E. coli tRNA"'®(GAC) G20 M3 were 
constructed: the G3:C70 and C4:G69 base pairs were mutated to A3:U70 and U4:A69, 
respectively. Aminoacylation rates of these tRNA^ variants were determined and the results 
are shown in Figure 10. Both these acceptor stem mutants are aminoacylated at a slightly 
higher rate than tRNA"~(GAC) G20 M3. However, they are still relatively poor substrates 
for ValRS compared to wild type tRNA^'^. The determinant(s) that can improve the 
aminoacylation activity of tRNA^'"(GAC) G20 does not appear to be located in the acceptor 
stem. 
tRNA'''" variants in the variable pocket cmd variable loop 
Positions outside of the acceptor stem were examined for their effects as positive or 
negative determinants of ValRS recognition. Comparison of the sequence of E. coli tRNA^*' 
and E. coli tRNA^ (Figure 7) shows that in the D-loop, T-loop, and variable regions, there 
are a total of five sequence differences between the two tRNAs; these are at positions 16, 17, 
20, 45 and 60. Four of the five nucleotides (positions 16, 17, 20, and 60) are in the variable 
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Figure 10. Time course of aminoacyiation with valine of wild type tRNA^"^ (closed circles), 
tRNA"''(GAC)G20 M3 U4: A69 (open triangles), tRNA'*^(GAC)G20 M3 
A3 .U70 (closed triangles), and tRNA'^°(GAC)G20 M3 (closed squares), and 
tRNA^(GAC)G20 (open circles). ValRS and tRNA concentrations are 0.1 
ng/jil and 2 piM, respectively. 
pocket (Ladner et al, 1975), formed by the tertiary interaction between bases in the D-loop 
and T-loop. Position 20 has akeady been mutated because it is a minor recognition element 
previously identified in tRNA^** (Liu, 1995). The bases at position 16 and 60 of 
tRNA'^(GAC) G20 were converted to those present at these positions in tRNA^** to 
investigate their effect on aminoacyiation. Individual substitution of U16 and U60 in tRNA"^ 
with C16 and C60, respectively, failed to increase valine acceptance. The time course of 
aminoacyiation of C16 and C60 variants are shown on Figure 11. A double mutant of C16 
and C60 is also a poor substrate for ValRS (Figure 11). 
U45 in the variable loop of tRNA^ is involved in a tertiary interaction with G10;C25 
(see Figure 1). Substitution of U45 in both tRNA"*'(GAC) G20 and tRNA""(GAC) G20 M3 
by G45 resulted in a consistent 3-fold increase in activity (Table 6) tRNA""(GAC) G20 
G45 M3 variant has 18% of wild type activity, an 18-fold increase over the tRNA^ mutant 
without G45 and M3. The guanine at position 45 appears to modulate aminoacyiation activity 
in the tRNA^*"-ValRS interaction 
tRNA^^" variants in the anticodon stem and loop 
Previous results from our laboratory indicated that mutation of U29;A41 in the 
anticodon stem of tRNA^*" to C29;G41 results in a 45-fold decrease in aminoacyiation 
activity (Liu, 1995). The decrease in activity is due mainly to a 18-fold increase in Km. The 
C29:G41 mutant with five C;G base pairs in the anticodon stem (Figure 2) has a structural 
resemblance to E. coli tRNA*^ which has four consecutive G;C base pairs in the anticodon 
stem (Figure 7), This could be the structural feature that is preventing E. coli tRNA"", 
complete with all the recognition nucleotides of tRNA^*", fi-om being efficiently 
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Figure 11. Time course of aminoacylation with valine of wild type tRNA^^ (closed circles), 
tRNA""=(GAC)G20 C16 (open triangles), tRNA'^(GAC)G20 C60 (open circles), 
and tRNA""(GAC)G20 C16 C60 (closed triangles). ValRS and tRNA 
concentrations are 0.1 ng/jal and 2 |iM, respectively. 
aminoacylated by ValRS. 
Single base pair mutations in the upper part of anticodon stem, which introduce 
sequences found in tRNA^** into tRNA""(GAC) G20 one base pair at a time, were 
constructed (Figure 12). Individual base pair substitutions at position 27:43, 28:42, and 
29:41 only slightly increase catalytic eflBciency (Table 7). The activity increases come from 
increases in Vnax of 3- to 7-fold. Conversion of all three base pairs at the top of the 
anticodon stem to those of tRNA^"' yielded a mutant tRNA*^, tRNA"^(GAC) G20 M3 
(Figure 12), which also has only a small increase in activity over the tRNA^ variant without 
M3 (Table 7). The increase in activity is largely due to a 5.9 fold increase in Overall, 
the individual base pair or combination of base pair mutations at the top of the anticodon 
stem do not significantly increase the activity of E. coli tRNA^. All variants have a much 
higher BC„, (10 to 18-fold increase) which indicates that the binding of the substrate to VaIRS 
is severely affected. 
In an attempt to identify additional structural feature(s) that are missing as recognition 
nucleotide(s) and/or acting as negative detemiinant(s) in E. coli tRNA""(GAC) G20, the 
entire anticodon stem and loop sequence of E. coli tRNA'^ was mutated to match the 
sequence of tRNA^''. The resulting molecule, tRNA""(GAC)(V-stem, V-loop) G20 (Figure 
12), has a relative Vmax/Kc of 0.36 compared to that of wild type tRNA^*" (Table 7). The 
Vnux is close to that of the wild-type tRNA^"*, and the Km is only elevated 3-fold. Since G45 
was found to modulate the activity of tRNA^** (Table 6), U45 in tRNA""(GAC)(V-stem, V-
loop) G20 was changed to G45. This tRNA'^" variant is now as active as wild type tRNA^'' 
(Table 7). The presence of G45 increases the activity almost 3-fold. 
Figure 12. Variants o f E .  c o l i  tRNA"^(GAC) G20 in the anticodon stem and loop. Shaded 
regions indicate sequence that was mutated to match the sequence found in 
tRNA^*'. 
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Table 7. Kinetic parameters for aminoacylation of E. coli tRNA'^ variants in the anticodon 
stem and loop with valine 
kT C^ tRNA 
Wild type 
tRNA"""* 
tRNA'^(GAC) 
G20 
tRNA""=(GAC) 
G20 C27:G43 
tRNA""(GAC) 
G20 C28;G42 
tRNA''''"(GAC) 
G20 U29;A41 
tRNA""(GAC) 
G20 M3' 
tElNA'''''(GAC) 
(V-stem,V-loop) 
G20 
tRNA^'"(GAC) 
(V-stem,V-loop) 
G20 G45 
tRNA'''"=(GAC) 
(V-stem,F-Ioop) 
G20 G45 
tRNA"'"(GAC) 
(F-steni,V-loop) 
G20 G45 
1.4 
17,1 
24.8 
18.4 
22.1 
14.7 
4.3 
1.5 
1.8 
16.5 
5.0 
0.58 
1.8 
4.2 
1.5 
3.4 
5.6 
5.1 
5.5 
2.1 
3.6 
0.03 
0.07 
0.23 
0.07 
0.23 
1.3 
3.4 
3.1 
0.13 
v max/km 
Variants (umoi/min/mg) 
Relative 
(Vmax/Kn.) 
(1.0) 
0.01 
0.02 
0.06 
0.02 
0.06 
0.36 
0.94 
0.86 
0.04 
Additional mutants were constructed to clarify the contribution of nucleotides of the 
anticodon stem and loop to valine accepting activity. One tRNA^ variant, tRNA""®(V-stem, 
F-loop) G20 G45, has the anticodon stem of tRNA^*' (V-stem) but retains the anticodon loop 
of tRNA^' (F-loop) except for C36 (Figure 12). The other tRNA'^ variant, tRNA""(F-
stem, V-loop) G20 G45, has the anticodon loop of tRNA^*" (V-loop) but retains the 
anticodon stem of tRNA^® (F-stem) (Figure 12). tRNA^'(V-stem, F-loop) G20 G45 is a 
very good substrate for ValRS with a relative Vnux/Km of 0.86 compared to that of wild type 
tRNA^*' (Table 7). On the other hand, tRNA^°(F-stem, V-loop) G20 G45 is a relatively 
poor substrate (Table 7). These resuhs indicate that detenninant(s) for converting 
tRNA"''(GAC) G20 into an efficient substrate for valyl-tRNA synthetase are in the anticodon 
stem, and that G45 is needed for maximal aminoacylation activity. 
Role of 3'-CCA of Aminoacyl-tRNA in Polypeptide Synthesis 
Function of 3'-CCA Variants of Vaivl-tRNA^*' in Polypeptide Synthesis 
Activity of valvl-tRNA^** variants with substitution for 3'-terminal adenine 
Our laboratory has reported that the universally conserved 3'-CCA sequence in 
tRNA^^ is not essential for all tRNA functions (Liu and Horowitz, 1994). Substitution of the 
usual 3'-terminal adenine (A) with either cytosine (C) or uracil (U) yields tRNA^*' variants 
that can still readily accept valine. Although tRNA^'^ with a terminal guanine (G), can be 
fully aminoacylated, it is a much poorer substrate for ValRS (see Introduction). When the 
aminoacylated tRNA^®* variants were tested in a poly(U3,G)-directed (Val, Phe) co-
polypeptide synthesis system (Ofengand et ai 1974), the tRNA^** variant terminating in G is 
quite active, whereas the C and U variants are inactive (Figures 13 and 14). Aminoacylated 
3'-CCA variants of valyl-tRNA^*' were used in these experiments to eliminate the effects of 
differences in aminoacylation efiBciency among the tRNA^** variants. With wild type valyl-
tRNA  ^" ,^ 15 pmol of valine are incorporated into hot TCA precipitable material {in vitro 
synthesized polypeptide) after 3 hours of incubation. This represents more than 16% of the 
input valyl-tRNA^*' (90 pmol). G76 valyl-tRNA^"* is also an active amino acid donor in 
polypeptide synthesis (Figure 13), however the rate of incorporation of valine into 
polypeptide is lower than that from the wild type tRNA. After 3 hours of incubation, about 5 
pmol of the total 90 pmol of valine is incorporated. In both wild type and 076 valyl-
tRNA^"^, the incorporation of valine into the polypeptide is almost linear over the three-hour 
time period. The U76 and C76 variants are inactive or very poor amino acid donors in 
polypeptide synthesis (Figure 13). 
Activity of valvl-tRNA^** variants with substitution for cvtidines near the 3'-end 
The activity of valyl-tRNA^"' variants with substitutions at positions 74 and 75 as 
valine donors in in vitro poly(U3,G)-directed (Val, Phe) co-polypeptide synthesis assays was 
also determined. The amounts of hot TCA precipitable radioactivity (polypeptide) after one 
hour of incubation were recorded for each mutant relative to the value obtained for wild type 
valyl-tRNA^** (Figure 14). The amount of radioactive valine incorporated into polypeptide 
from the mutant tRNAs is between 30 to 60% of that from wild type valyl-tRNA^*'. This is 
also true for the double mutant, U74U75 (-UUA), even though it is a poor substrate for 
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Figure 13 Poly(U3,G)-directed (Val,Phe) copolypeptide synthesis. The time couse of ["H]-
valine incorporation into polypeptide from wild type tRNA^** (-CCA; closed 
circles), G76 variant (-CCG; open circles), U76 variant (-CCU; closed triangles), 
and C76 variant (-CCC, open triangles). 
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variant in the 3'-end. 
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aminoacylation. These results indicate that mutations at position 74 and 75 do not severely 
affect the amino acid donor activity of valyl-tRNA^'^. 
Interaction of Elongation Factor TurGTP and Aminoacvl-tRNA 
The co-polypeptide synthesis assay determines the ability of different tRNA^** variants 
to successfully complete several rounds of the elongation cycle to produce the acid 
precipitable (Vai, Phe) co-polypeptide. Experiments were designed to identify the step or 
steps during the elongation cycle at which the pyrimidine substituted U76and C76 tRNA^"* 
are not functional. The elongation cycle can be broken down into four discrete steps; (1) 
ternary complex formation, (2) binding of aminoacyl-tRNA at the A-site, (3) peptide bond 
formation at the peptidyltransferase center, and (4) translocation step/P-site binding (see 
Introduction). Identifymg the step(s) at which the function of tRNA^'' mutants is impaired 
will contribute to an understanding of interactions between tRNA and components of the 
protein synthesis machinery, such as elongation factor Tu (EF-Tu), ribosomal RN A/protein, 
etc. 
Ternary complex formation with 3'-terminal variants of valvl-tRNA^** 
The ability of aminoacylated native tRNA^®* (containing naturally occurring 
nucleotide modifications), wild type transcribed tRNA^"*, and each of the position-76 variants 
(G, C, and U) to form a ternary complex with EF-Tu and GTP was determined by a 
hydrolysis protection assay. The aminoacyl-tRNA linkage is unstable and is readily 
hydrolyzed; the rate of hydrolysis of valyl-tRNA^'' is dependent on pH. As the pH increases, 
the rate of spontaneous hydrolysis of the aminoacyl-ester linkage increases (results not 
shown). Valyl-tRNA^'^ has the most stable aminoacyl-ester linkage of all aminoacyl-tRNAs, 
and all mutant valyl-tRNA^*" variants are hydrolyzed at the same rate. Formation of a ternary 
complex with EF-Tu:GTP protects the aminoacyl ester bond from hydrolysis. As a result of 
preliminary tests (results not shown), the hydrolysis protection experiments with tRNA^®* 
were carried out at pH 8.0 and 37°C. 
Figure 15 shows that in the absence of the elongation factor (curve labeled BSA), 
hydrolysis of the ester linkage follows a first order decay rate; after 3 hours, about 10% of 
the original valyl-tRNA^"* remains unhydrolyzed. In the presence of a 10-foId molar excess 
of EF-Tu:GTP, the elongation factor protects the aminoacyl bond of the wild-type and the 
G76 variant of valyl-tRNA^'' from hydrolysis (Figure 15); in both cases, nearly 95% of valyl-
tRNA^®' remains intact. The ester linkage of the U76 mutant of valyl-tRNA^'' is also 
protected from hydrolysis by EF-Tu:GTP, but to a lesser degree; about 80% of U76 valyl-
tRNA^"* remains unhydrolyzed after 3 hours of incubation (Figure 15). In the C76 mutant of 
valyl-tElNA^®', the aminoacyl bond is, however, only minimally protected from hydrolysis by 
EF-Tu;GTP; the rate of hydrolysis approaches that of valyl-tRNA^'* in the absence of EF-
Tu;GTP (Figure 15). Since in the absence of EF-Tu:GTP the rate of spontaneous hydrolysis 
of the ester bond is the same for all valyl-tRNA^ ** variants regardless of the nature of 
nucleotide at the 3'-terminal position (Figure 15; curve labeled BSA), differences in the rates 
of hydrolysis in the presence of EF-Tu;GTP are indicative of EF-Tu:GTP's affinity for a 
particular valyl-tRNA^** variant. The hydrolysis protection results (Figure 15) clearly 
indicate that the mutants with 3'-terminal pyrimidines, particularly the C76 variant, are 
discriminated against in the formation of a ternary complex. EF-Tu:GTP evidently has a 
greater affinity for valyl-tRNA^®' terminating in purines 
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Figure 15. Ternary complex formation between EF-Tu;GTP and E. coli valyl-tRNA^^ at pH 
8.0. The rate of hydrolysis of valylated wild type tRNA^®", 0.3 loM (A76; closed 
circles) and variants (0.3 ijM) with nucleotide substitutions at their 3' termini: 
G76 (open circles), U76 (closed triangles), and C76 (open triangles) was measured 
in the presence of a 10-foId molar excess of EF-Tu;GTP. The rate of hydrolysis of 
valyl-tRNA^*' in the presence of bovine serum albumin (BSA) is shown for 
comparison (closed squares). 
79 
Ternary complex formation with valvl-tRNA^" variants having substitution for the cvtidines 
near the 3'-end 
Similar hydrolysis protection assays were carried out to monitor the interaction with 
EF-Tu:GTP of valyl-tRNA^*' variants with substitutions at position 74 and/or 75 of the 
universally conserved 3'-CCA end. For mutants at position 74, the results of the hydrolysis 
protection assay are shown on Figure 16. EF-Tu:GTP protects the aminoacyl ester bond of 
all position 74 mutants of valyl-tRNA^'' against hydrolysis as well as that of wild type valyl-
tRNA^"^. In all cases, a 10-fold molar excess of EF-Tu;GTP completely protects the 
aminoacyl linkage from hydrolysis at pH 8.0 for a 90-minute incubation at 37°C. 
For tRNA^®' mutants at position 75, the results of the hydrolysis protection assay are 
shown on Figure 17. The results were similar to those for mutants at position 74. In the 
presence of 10-fold molar excess of EF-Tu:GTP, all mutants at position 75 show complete 
protection of their aminoacyl ester bond at pH 8.0 over a 90-minute incubation at 37°C. 
The hydrolysis protection of the U74U75 double mutant (3'-end sequence -UUA) by 
EF-Tu:GTP was also monitored. This variant is completely protected from spontaneous 
hydrolysis in the presence of 10-fold molar excess of EF-Tu:GTP (Figure 16). 
Dissociation constants of ternary complexes 
The hydrolysis protection assay provides a qualitative measure of the ability of 
aminoacyl-tRNA to interact with EF-Tu:GTP. To obtain a more quantitative assessment, 
dissociation constants of the ternary complexes were determined using a ribonuclease 
protection assay (Louie and Jumak, 1985; see Methods). The dissociation constant (Ka) of 
the ternary complex with native valyl-tRNA^®' was determined to be 8 nM (Table 8), this 
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Figure 16. Ternary complex formation between EF-Tu:GTP and £. coli valyl-tRNA^'' at pH 
8.0. The rate of hydrolysis of valylated wild type tRNA^'', 0.3 {oM (C74; closed 
circles) and variants (0.3 ^iM) with nucleotide substitutions at position 74: A74 
(open circles), G74 (closed triangles), and U74 (open triangles) was measured in 
the presence of a 10-fold molar excess of EF-Tu:GTP. The rate of hydrolysis of a 
double mutant (U74U75; open squares) was also measured. The rate of hydrolysis 
of valyl-tRNA^^ in the presence of bovine serum albumin (BSA) is shown for 
comparison (closed squares). 
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Figure 17. Ternary complex formation between EF-Tu:GTP and E. coli valyi-tRNA^*" at pH 
8.0. The rate of hydrolysis of valylated wild type tRNA^^, 0.3 |iM (C75; closed 
circles) and variants (0.3 nM) with nucleotide substitutions at penultimate 
position; A75 (open circles), G75 (closed triangles), and U75 (open triangles) was 
measured in the presence of a 10-foId molar excess of EF-Tu;GTP, The rate of 
hydrolysis of valyl-tRNA^"' in the presence of bovine serum albumin (BSA) is 
shown for comparison (closed squares). 
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Table 8. Dissociation constants of ternary complexes with 3'-CCA variants of valyl-tRNA 
variants 
Valyl-tRNA^"' Variants Kj (nM) Fold Increase 
Native tRNA^" 8 ± 2.6 0.36 
Wild type (A76) 22 ± 3.0 (1.0) 
A76-^G76 47 ±4.2 2.1 
A76^U76 351 ±45 16 
A76 C76 > 1 ^xM >45 
C74->A74 39 ±1.2 1.8 
C74->G74 25 ±2.1 I . I  
C74 -)• U74 47 ± 2.2 2.1 
C I S M S  35 ±2.5 1.6 
C75->G75 19 ±3.2 0.9 
C75->U75 26 ±2.4 1.2 
C74 C I S  U74 U75 27 ± 3.5 1.2 
agrees well with the previously reported value of 7.1 nM (Louie and Jumak. 1985). The Kd 
of the ternary complex with in vitro transcribed wild-type valyl-tRNA^** is somewhat higher, 
22 nM. Nucleotide modifications in tRNA evidently increase the affinity of EF-Tu for valyl-
tRNA^**. Kd values for complexes with G76 and U76 valyl-tRNA^*' are 47 and 351 nM 
respectively, while that for the C76 mutant is considerably higher and is estimated to be in the 
micromolar range (Table 8). 
The Kd values for the ternary complexes of position 74 and 75 mutants of tRNA^ **, 
determined by the ribonuclease protection assay, are listed in Table 8. Kd values are all 
within 2.1-fold that of the ternary complex with wild type valyl-tRNA^*'. 
Ternary complex formation with 3'-terminal variants of alanvl-tRNA"^'and phenvlalanvl-
tRNA^*" 
To examine whether base-specific recognition of the 3'-terminus by EF-Tu:GTP can 
be generalized to other aminoacyl-tRNAs, ternary complex formation with 3'-terminal 
variants of E. coli tRNA'^' and tRNA"" was also studied. The wild-type transcript of 
tRNA'^® and each of the position-76 variants (G, C, and U) can be fully aminoacylated with 
alanine at high concentrations of purified alanyl-tRNA synthetase (AlaRS) (Liu, 1995). 
Hydrolysis protection assays performed with alanyl-tRNA'^' variants (Figure 18), gave 
resuhs similar to those found with valyl-tRNA^^ variants (Figure 15). As in the hydrolysis 
protection experiments with valyl-tRNA^*", those with alanyl-tRNA'^" were carried out at pH 
8.0. Wild type alanyl-tRNA'^ and the G76 mutant readily form a ternary complex; the U76 
mutant interacts with EF-Tu:GTP also, but to a lesser extent. Cytosine at the 3'-terminus 
greatly reduces formation of the ternary complex with EF-Tu; GTP In the absence of 
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Figure 18. Ternary complex formation between EF-Tu:GTP and E. coli alanyl-tRNA'^^ at pH 
8.0. The rate of hydrolysis of alanylated wild type tRNA'^', 0.3 (iM (A76; open 
circles) and variants (0.3 piM) with nucleotide substitutions at their 3' termini; 
G76 (closed circles), U76 (closed triangles), and C76 (open triangles) was 
measured in the presence of a 10-fold molar excess of EF-Tu:GTP. The rate of 
hydrolysis of alanyl-tRNA'^ in the presence of bovine serum albumin (BSA) is 
shown for comparison (closed squares). 
elongation factor (curve labeled BSA in Figure 18), the hydrolysis of all alanyl-tRNA'^ 
follows a first order decay rate. The ester linkage of alanyl-tRNA'^" is not as stable as that of 
valyl-tRNA^*' at pH 8.0, and the degree of protection afforded by interaction with EF-
Tu:GTP is somewhat lower than with valyl-tRNA^"'. 
In experiments using partially purified phenylalanyl-tRNA synthetase (see Methods), 
it was found that tRNA^ variants with base substitutions for the 3'-terminal A76 can be 
aminoacylated. The time course of aminoacylation of wild type tRNA^" and 3 '-terminal 
variants (C, G, and U) are shown on Figure 19. tRNA^ C76 is readily aminoacylated 
whereas the G76 and U76 variants are poor substrates for aminoacylation. At high 
synthetase concentrations, the wild type and C76 variant of E. coli tRNA^® could be fully 
aminoacylated, while the G76 and U76 variants of E. coli tRNA^ were only 25% 
aminoacylated (results not shown). 
Hydrolysis protection assays were performed at pH 8.0 with the phenylalanyl-tRNA^ 
variants, and the results are similar to those observed with valyl-tRNA'"' and alanyl-tRNA"^ 
variants (Figure 20). Wild-type phenylalanyl-tRNA"" and the G76 mutant readily form 
ternary complexes; the U76 mutant of phenylalanyl-tRNA^' is also protected by EF-Tu:GTP 
This high level of protection is different fi-om that of the U76 variants of tRNA^"' and 
tRNA'^' (Figure 15 and 18). Again C at the 3'-terminus greatly reduces formation of the 
ternary complex with EF-Tu;GTP. In conclusion, the base-specific recognition of the 3'-
terminal base is a general mechanism for recognition of aminoacyl-tRNAs by elongation 
factor Tu. 
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Figure 19. Time course of aminoacylation with phenylalanine of wild type E. coU tRNA*^" 
(closed circles), tRNA^''"' C76 (open circles), tRNA^" G76 (closed triangles), and 
tRNA"" U76 (open triangles). RNA and phenylalanyl-tRNA synthetase 
concentrations are 2.6 and 0.04 |ag/|al, respectively. 
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Figure 20. Ternary complex formation between EF-Tu;GTP and E. coli phenylalanyl-
tRNA"" pH 8.0. The rate of hydrolysis of phenylalanylated wild type tRNA""", 
0.3 |iM (A76; closed circles) and variants (0.3 jiM) with nucleotide substitutions 
at their 3' termini. G76 (open circles), U76 (closed triangles), and C76 (open 
triangles) was measured in the presence of a 10-fold molar excess of EF-Tu.GTP. 
The rate of hydrolysis of phenylalanyl-tRNA®^ in the presence of bovine serum 
albumin (BSA) is shown for comparison (closed squares). 
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DISCUSSION 
Identity Elements in E. coli tRNA^** 
To understand the molecular basis for the recognition of E. coli tRNA^"^ by ValRS, 
steady-state kinetic studies of the aminoacylation of in vitro transcribed tRl'M^ "' variants 
were conducted to determine the effects of each mutation on activity. The importance of 
anticodon positions A35 and C36 as major recognition determinants of tRNA^"^ was 
demonstrated by making nucleotide substitutions. Mutations introduced into these two 
positions severely reduced the aminoacylation activity of tRNA^*' variants (Schulman and 
Pelka, 1988; Tamura et al., 1991; Chu et al., 1992). The identity swap experiments with 
yeast tRNA'''^, E. coli tRNA®^, and tRNA'^' (Liu, 1995) further demonstrated and confirmed 
the importance of positions A3 5 and C36 of the anticodon in the recognition of E. coli 
tRNA^®' by ValRS. Introduction of C36 into E.coli and yeast tRNA®  ^and A35 into E. coli 
tRNA'^^ dramarically increased the aminoacylation efficiency of these tRNAs with valine. In 
addition, the discriminator base A73 (Liu, 1995; Tamura et al., 1991) and position G20 (Liu, 
1995) in the D-loop were identified as recognition nucleotides of tRNA^''. In the present 
study, kinetic analysis of tRNA^®' variants and identity swap experiments with E. coli 
tRNA'^ identified G45 in tRNA^^ as a minor recognition nucleotide (Table 7). Our present 
recognition model for tRNA^*'-ValRS interaction specifies a set of five recognition 
nucleotides in tRNA^**; these include A35, C36, A73, G20, and 045. In addition, a wobble 
base pair in the middle of the acceptor stem was found to aflfect the aminoacylation efficiency 
of tRNA^*" by ValRS (Table 1 and 5). The efficient recognition of tRNA^"* by ValRS 
requires the acceptor stem to be in a normal A-form helbc. This conclusion is based on 
results of kinetic studies of tRNA^** variants, identity swap experiments of yeast tRNA"* and 
E. coli tRNA"^' (Liu, 1995), and "F NMR experiments with 5-fluorouracil-substituted 
tRNA^*'(Liue/a/., 1997). 
Role of Acceptor Stem of tRNA'"' in the Recognition bv ValRS 
Even though many tRNAs have major recognition nucleotides in their acceptor stem 
helix, especially in the first three base pairs (see Introduction), kinetic studies of acceptor 
stem variants of tRNA^"* did not reveal any recognition nucleotides in the acceptor stem 
helix. In general, aminoacylation activity of tRNA^^ is not significantly affected by Watson-
Crick base pair substitutions at different positions of the acceptor stem helix. These resuhs 
differ fi-om those of Tamura et al. (1991) (see Result) who reported that changing the 
U4;A69 base pair to A4:U69 decreases aminoacylation activity 5.3-fold and replacing 
G3:C70 with C3:G70 lowers activity 2.3-foId. This disagreement is not due to differences in 
experimental conditions: Tamura and coworkers used 19.2 (jM valine (sub-optimal) in their 
aminoacylation reaaion, and we used 100 (iM (twice Ka). If mutations in a tRNA affect 
ValRS's affinity for the amino acid in the aminoacylation reaction, as in the case of tRNA^*" 
(Ibba et al., 1996), then it is possible that the decrease in activity of the acceptor stem 
variants, observed by Tamura et al. (1991), is due to determinants for valine affinity in 
tRNA^®*. However, wild-type and acceptor stem variants of tRNA^'' have similar Km for 
valine in the aminoacylation reaction (Table 2). Furthermore, aminoacylation kinetic studies 
of C3 .G70 and A4;U69 variants under condition of sub-optimal valine concentration (10 }iM) 
showed near wild-type activities (Table 3). These resuhs indicate that Watson-Crick base 
pair mutations in the acceptor stem of tRNA^ ®' do not affect the valine affinity of ValRS for 
aminoacylation, and VaIRS does not appear to recognize any specific base or base pair in the 
acceptor stem. 
Introduction of G:U base pairs into the acceptor stem helix did not significantly affect 
aminoacylation activity except when the G:U base pair is located at position 4.69 or 3:70 to a 
lesser extent. tRNA^®* variants at position 4:69 can be divided into two groups: one with 
good aminoacylation activity and one with relatively poor activity (Table 9). The base pair 
U4: A69 in the center of the acceptor stem of tRNA^*' can be substituted by other Watson-
Crick base pairs such as C4:G69, and A4:U69 or even the non-canonical base pair U4:C69 
with only a relatively small decrease in the specificity constant (Vnux/Km) for aminoacylation. 
In general, tRNA^"* variants, having a base pair at positions 4:69 that maintains a normal A-
form acceptor stem helix, have good aminoacylation activity; these variants have Watson-
Crick base pairs or an U;C base pair at position 4:69. The U:C pair in a RNA double helix is 
believed to maintain a regular A-form hehcal structure as shown by the crystal structure of a 
12 base-pair RNA duplex (Holbrook etal., 1991). The slightly lower activity observed with 
G4:C69 in the acceptor stem helix could be the result of increased rigidity of the acceptor 
stem helbc rather than the absence of specific recognition at base pair 4:69. An energy 
calculation of intramolecular interactions between the bases in a double-stranded helix 
(DeVoe and Tinoco, 1962) showed that the largest contribution to helical stability came fi'om 
vertical stacking of bases. Studies of oligoribonucleotides had shown that helical stability is 
strongly dependent on sequence (Borer et al., 1974). In particular, G:C over G:C is more 
stable than either G;C over C;G or C:G over G:C. 
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Table 9. Kinetic parameters for aminoacylation of tRNA^** variants at position 4:69 in the 
acceptor stem; A-Form Helix vs. Distorted Helix 
Val tRNA 
A-Form Helix 
Wild Type 1.4 
Vnum/Km 
lol/min/mg) 
5.0 3.6 
Relative 
(Vm«/K„) 
(1.0) 
U4:A69 
A4:U69' 
1.6 4.9 3.1 0.86 
U4;A69 
C4:G69" 
1.4 4.3 3.0 0.83 
U4;A69 ^ 
G4:C69 
6.2 6.8 1.1 0,31 
U4;A69 
U4*C69 
2.9 5.8 2.0 0.56 
Distorted Helix 
U4;A69 -) 
G4.U69 
20.0 1.9 0.095 0.026 
U4:A69 -j 
U4:G69 
10.4 6.2 0.60 0.17 
U4:A69 -> 
A4*G69 
8.9 6.1 0.69 0.19 
Results from Liu (Liu, 1995) and Vahid Feiz shown here for comparison. 
Therefore, the presence of five consecutive guanines on one strand and cytosines on the other 
in G4:C69 tRNA^*' variant (Figure 2) have the potential of having a very rigid acceptor stem 
helix. 
On the other hand, tRNA^*' variants with poor activities have G:U base pairs or an 
A;G base pair at position 4; 69 that can cause distortion of the normal A-form helical 
structure (Table 9). Substitution by the wobble base pair U4:G69 or G4;U69 results in a 
large decrease in specificity constant (Table 9). NMR experiments of tRNA^** variants 
with G.FU base pairs at positions 2:71, 3:70 and a FU:G base pair at position 4:69 in the 
acceptor stem showed a gradual downfield shift of the resonance corresponding to FU4 
toward a region of "p NMR spectrum that corresponds to FU residues in single-stranded 
regions of tRNA^"* (Liu, 1995; Chu and Horowitz, unpublished). This is strong evidence for 
changes in the local structure of the acceptor stem helix around base pair 4:69 when a G:U 
base pair is present at or in close proximity to this location. A strong correlation between the 
chemical shift of resonance FU4 in the "F NMR spectrum of different tRNA variants and 
their relative aminoacylation activity was also observed: as the degree of downfield shift of 
resonance FU4 in a tRNA variant increases, the aminoacylation activity of that tRNA variant 
decreases (Liu, 1995). 
The local distortion of the acceptor stem helix in the presence of a G:U base pair is 
most likely due to differences in base stacking with the adjacent base pairs. G:U base pairs 
area very common structural feature of RN A molecules. This structural feature is clearly 
evident in several crystallographic and NMR struaures containing G:U base pairs in helical 
stems. On the basis of the yeast tRNA"" crystal structure, Mizuno and Sundaralingam 
(1978) predicted that base pairs to the 5' side of the U of a G:U pair and the 3' side of the G 
will stack favorably with the G:U, while base pairs on the opposite side should stack very 
poorly on the G;U. Available structures of RNA support this hypothesis, and this preferential 
base stacking is believed to cause a local helical distortion. In the NMR structure of PI helix 
from Group I self-splicing introns, AUain and Varani, (1995), concluded from their analysis of 
the conserved G;U wobble base pair in a double helical structure that G:U wobble base pairs 
cause a local distortion to the regular A-form helix. In the crystallographic structure of yeast 
tRNA'^ (Westhof et al., 1985), there are two G:U base pairs in the helical regions. Both 
G.U base pairs are flanked by two G:C base pairs, as in the case for the mutant tRNA^"* 
which has a G4;U69 base pair in the acceptor stem. For both G;U base pairs in the acceptor 
and anticodon stem helices of yeast tRNA'^, a preferential base stacking was observed as 
predicted by Mizuno and Sundaralingam. In a NMR analysis of Helix I of the 5S RNA of E. 
coli, the G;U base pair also showed strong base stacking interaction with the base on the 5' 
side of the U and the 3' side of the G, while base pairs on the opposite side stacked very 
poorly (White era/., 1992). 
The identity swap experiments with yeast tRNA"^ (Table 5) and E. coli tRNA'^" (Liu, 
1995) agree well with the results of G:U base pair substitutions at position 4:69 and 3:70 in 
tRNA^**. In order for these tRNAs to be efficient substrates for ValRS, the G:U base pairs at 
position 3:70 of tRNA"^ and 4:69 of yeast tRNA^ needed to be substituted with Watson-
Crick base pairs. The G;U base pair in the acceptor stem of tRNA'^ and yeast tRNA^ acts 
as a negative determinant to prevent recognition by ValRS. 
A NMR study of an 8-base pair RNA duplex concluded that the local geometry of 
A;G pair in a RNA helix resembles that of a G:U wobble base pair (SantaLucia and Turner, 
1993). An A4:G69 base pair substitution at this location also caused a significant decrease in 
specificity constant (Table 9). A large increase in K,n was responsible for the decreases in 
specificity constant in this mutant tRNA. From these experimental resuhs, it can be 
concluded that the U4: A69 base pair in tRNA^** does not contain fiinctional groups that are 
directly recognized by VaIRS, but ValRS needs to have a normal A-form helical structure at 
this position in the acceptor stem. The acceptor stem of tRNA^** may need to be in an A-
form helix for proper positioning of the 3'-CCA into the active site of ValRS. 
Even though the results of our kinetic studies do not indicate base-specific 
recognition of the acceptor stem of tRNA^'' by ValRS, other results indicate that ValRS 
makes contact with the acceptor stem of tRNA^** during aminoacylation. RNase VI 
footprinting experiments (Derrick, 1991) indicate that VaIRS protects the 5' phosphodiester 
bonds of positions 66 and 69 in the acceptor stem fi-om cleavage. In "F-NMR experiments, 
interaction of ValRS with 5-fluorouracil-substituted tRNA^** results in a loss of intensity of 
resonances corresponding to FU67, and a broadening and shifting of FU4 (Chu and 
Horowitz, 1991). 
Role of Tertiary Interactions of tRNA'"' in the Recognition by ValRS 
Four of the nine tertiary interaction, first identified in yeast tRNA"*, have conserved 
sequences in all non-mitochondrial tRNAs fi"om prokaryotic to eukaryotic organisms (Table 
10). Therefore, it is very unlikely that these nucleotides are used by the aminoacyl-tRNA 
synthetases to specifically recognize their respective cognate tRNAs. The remaining five 
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Table 10. Tertiary Interactions for E. coli elongator tRNAs 
Tertiary Interaction 
G19-C56 
G18-U55 
U54-A58 
U8-A14 
% of tRNAs 
100 
100 
100 
100 
15-48 
G15-C48 
A15-U48 
G15-G48 
13-22-46 
C13-G22-G46 
others 
9-23-12 
A9-A23-U12 
C9-G23-C12 
G9-C23-G12 
others 
45-10-25 
G45-G10-C25 
U45-G10-C25 
G45C10-G25 
G45-G10-U25 
others 
85 
10 
5 
70 
30 
65 
9 
9 
15 
40 
20 
10 
10 
20 
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Table 10. (continued) 
Tertiary Interaction % of tRNAs 
26-44 
A26-G44 30 
G26-A44 20 
A26-C44 20 
A26-U44 10 
others 20 
tertiary interactions involve positions 15-48, 26-44, 13-22-46, 9-23-12, and 45-10-25; the 
last three involve triplet interactions. The frequency of occurrence of particular nucleotides 
in these five tertiary interaction are shown for all E. coli elongator tRNAs in Table 10 E. 
coli tRNA^®* happens to contain nine of the tertiary interactions most commonly found in E. 
coli elongator tRNAs. Tertiary nucleotides at positions 15-48, 13-22-46, and 9-23-12 of 
tRNA^** are the same as those found at these positions in 85, 70, and 65%, respectively, of 
other E. coli elongator tRNAs. Hence, special attention is given to the remaining two 
tertiary interactions, 26-44 and 45-10-25, for their roles in the recognition process by valyl-
tRNA synthetase. 
A single base substitution of U45 for G45 in tRNA^*' results in a moderate decrease 
in aminoacylation efficiency (Table 1). The effect of an equivalent mutation on the 
aminoacylation efficiency of E. coli tRNA'''" by E. coli PheRS was much more pronounced; a 
single base substitution of U45 to G45 resulted in a 7-fold reduction in specificity constant 
(Peterson and Uhlenbeck, 1992). The U45-G10-C25 tertiary base triplet was therefore 
identified as a recognition element of E. coli tRNA^ in the E. coli PheRS system. The 
importance of G45 in the aminoacylation of a tRNA by ValRS was not clearly evident until 
the results of the identity swap experiment with E. coli tRNA"" were examined. The 
aminoacylation activity with valine of E. coli tRNA^ variants was consistently increased by 
about 3-fold by the presence of G45 (as in tRNA^ *') in place of the U45 present in tRNA"" 
(Table 6 and 7). These results suggest that 045 is involved in the recognition of tRNA^'^ by 
ValRS. U45 of E. coli tRNA"" is the only other recognition nucleotides identified in the 
variable loop of a tRNA with a short variable loop. The variable loops of E. coli tRNA^ and 
tRNA^", both with long variable loops, have been implicated in the recognition process of 
their respective synthetases (Himeno et ai, 1990). 
Single base substitutions of A26 to G26 or G44 to A44 result in moderate decreases 
in aminoacylation activity (Table 4). These results are in contrast to the same mutations of 
yeast tRNA"" that showed wild type activities in the yeast phenylalanyl-tRNA synthetase 
(PheRS) system (Sampson et ai, 1990) Aminoacylation kinetic studies of these yeast 
tRNA"" variants indicated that they all have lower Km values which result in higher 
specificity constants for these variants than for wild type tRNA"". Perhaps the mutations at 
this tertiary base pair in the sequence context of yeast tRNA"" are less disruptive to the 
overall structure, or yeast phenylalanyl-tRNA synthetase is more tolerant of possible 
conformational changes caused by these mutations. A double-mutation in tRNA^**, A26-G44 
—> G26 -A44, that restores an A;G interaction increased the aminoacylation activity to the 
level of wild type tRNA^*" (Table 4), The A26-G44 tertiary interaction in E. coli tRNA"" 
were identified as recognition nucleotides because a structurally conservative substitution of 
G26-A44 caused a 14-fold decrease in activity (Peterson and Uhlenbeck, 1992). This E. coli 
tRNA^ variant is believed to be structurally similar to its wild type counterpart based on its 
normal lead cleavage rate (Peterson and Uhlenbeck, 1992). Lead cleavage in tRNA"" is very 
sensitive to the integrity of the core region of a tRNA (Behlen et al., 1990). The present in 
vitro analyses showed that the 26-44 tertiary interaction is not critical for aminoacylation of 
tRNA^** as long as the A-G/G-A tertiary interaction is maintained. 
Identity Swap Experiments 
Availability of three active chimeric substrates for ValRS: yeast tRNA^ (GAC) A4 
(Table 5), £. coli tRNA '^(GAC) (V-stem, F-loop) G20 G45 (Table 7), and E. coli 
tRNA'^''(UAC) A3:U70/G3:C70 (Liu, 1995), makes it possible to eliminate a substantial 
number of additional nucleotides as potential recognition sites for ValRS. For example, the 
G5;C68 base pair in the acceptor stem of tRNA^*" is A5;U68 and C5:G68 in yeast IRNA"* 
(GAC) A4 and E. coli tRNA'^(UAC) A3;U70/G3:C70, respectively. Of the 76 nucleotides 
in tRNA^^, 23 can be eliminated fi"om consideration because they are either conserved or 
semi-conserved nucleotides in all E. coli tRNAs. Of the remaining 53 nucleotides, 7 have 
been changed to at least two other nucleotides and an additional 13 to one other nucleotide 
without significantly altering the aminoacylation kinetics. Of the remaining 33 nucleotides, 4 
nucleotides at base pairs 4.69 and 29 41 are not specifically recognized by ValRS; rather the 
wobble base pair at position 4:69 and the C;G base pair at position 29:41 induce structural 
features that are unfavorable for efficient aminoacylation. Of the remaining 29 nucleotides, 
identity swap experiment with yeast tRNA"* helped to exclude 12. The efficient valine-
accepting chimeric yeast tRNA"^, tRNA"*(GAC) A4 (Table 5), has eight nucleotides in the 
T-stem, position 16, base pairs 5:68 and 31:59 that are different from those in tRNA^*' 
Seven of the eight nucleotides in the T-stem of tRNA^** have never been individually tested 
as synthetase recognition nucleotides. Finally, five of the remaining 17 nucleotides have been 
identified as recognition nucleotides and the remainder (mainly in the D-Stem and the top two 
base pairs in the anticodon stem) have not yet been tested. Thus, a limited number of 
additional nucleotides for ValRS recognition may still be possible. 
The ability to switch the identity of yeast tRNA^(GAA) to a valine acceptor by 
making two nucleotide substitutions, A36 to C36 and G4 to A4, suggests that the overall 
structure of tRNA^'' is very similar to that of yeast tRNA^ This similarity allows us to 
visualize the recognition nucleotides of tRNA^*" in the scaffold of the well-established crystal 
structure of yeast tRNA'*'" (Figure 21). The recognition nucleotides reside in four regions of 
the tRNA tertiary structure; the variable pocket (G20), the central core (G45), the anticodon 
loop (A3 5 and C36), and the acceptor end (A73). All four regions are also sites at which 
other tRNA synthetases interact with tRNA as shown by both in vivo and in vitro 
experiments (Schulman, 1991; Pallanck et ai, 1995). 
Although the identity swap experiments with yeast tRNA"" and £. coii tRNA'^" (Liu, 
1995) proved successfiil, the identity swap experiment with E. coli tRNA'''" was not 
completely satisfying. E. coli tRNA'*'" was converted to an efficient substrate for ValRS only 
after wholesale substitution of the entire anticodon stem, in addition to converting A3 6 to 
C36, U20 to G20, and U45 to G45 (Table 7). It is clear from aminoacylation kinetic 
100 
A73 
G20 
Figure 21. Synthetase recognition nucleotides of E. coli tRNA^** in the structural backbone 
of yeast tRNA'^. The tRNA backbone is depicted in black, and the recognition 
nucleotides are shown in gray. The structure was generated by the program 
RasMol (R. Sayle). 
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studies of tRNA^*" variants that several mutations at base pairs 29:41 and 30:40 yield active 
substrates for ValRS (Liu, 1995). The anticodon stems of active chimeric yeast 
tRNA^(GAC) A4 and E. coli tRNA'^'(UAC)A3:U70/G3:C70 (Liu, 1995) differ from 
tRNA^** in three base pairs and one base pair, respectively. Wrede et al. (1979) found that 
the conformation of the anticodon loop of initiator tRNAs can be influence by the sequence 
of the anticodon stem. Therefore, base substitutions in the anticodon stem of E. coli tRNA"*' 
may be needed for the anticodon loop to have the correct conformation needed for 
productive recognition by ValRS. Giege et al. (1993) pointed out that nucleotides that reside 
close to one another in the tertiary structure may define a unique structural feature of that 
region of the tRNA molecule. It is possible for the same mutations to have different effects 
in the sequence context of different tRNAs. The identity swap experiments with E. coli 
tRNA®"**^ were not unique. In fact, Peterson and Uhlenbeck (1992) reported that the most 
active chimeric substrates of yeast tRNA"* and E. coli tRNA'^'^ for E. coli phenylalanyl-
tRNA synthetase have about 30% and 2%, respectively, of wild-type £. coli tRNA"" activity. 
Schulman and Pelka (1988) found that tRNA'^'"* with a valine anticodon has only 10% of the 
wild-type tRNA^*" activity. 
The studies on E. coli tRNA^*' variants and the identity swap experiments have 
shown the overwhelming importance of the anticodon bases A3 5 and C36 as synthetase 
recognition nucleotides. The discriminator base A73 and G20 in the variable pocket had also 
been shown to be recognized by ValRS in a specific manner. 045 of tRNA^** is identified as 
a recognition nucleotide mainly through identity swap experiments with E. coli tRNA"". Our 
study also suggests that the A-form conformation of the acceptor stem, especially around 
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base pair 4:69, is recognize by ValRS. The present view of the identity elements of tRNA^** 
includes five nucleotides: A35, C36, A73, G20 and G45, plus an A-form helical 
conformation of the acceptor stem. 
Role of 3'-CCA of Aminoacyl-tRNA in Polypeptide Synthesis 
Function of 3'-CCA Variants of Valvl-tRNA^** in Polypeptide Synthesis 
The universal conservation of 3'-CCA sequence suggests that it is critical for the 
function of tRNA in polypeptide synthesis. However, Liu (1995) has found that many 
tRNA^** variants with modifications at the universally conserved 3'-CCA are substrates for 
ValRS in aminoacylation. The C76 and U76 tRNA^'*^ variants are highly efficient substrates 
for ValRS, while G76 variant is a very poor substrate (Liu and Horowitz, 1994). The ability 
of tRNA^ "^ with altered 3'-CCA sequence to function in polypeptide formation in vitro was 
tested in a poly(U3,G)-directed (Val, Phe) co-polypeptide synthesis system (Liu, 1995). 
Amino acid donor activity of tRNA^*' variants were tested using aminoacylated tRNA^*' in 
order to eliminate differences in aminoacylation efficiency of different tRNA^®* variants. 
Previous in vitro polypeptide synthesis experiments (Liu, 1995) used the heterologous yeast 
tRNA^ as the phenylalanine donor in the copolypeptide synthesis system. The present 
experiments utilized E. coli tRNA^ as the phenylalanine donor and resulted in a more 
efficient synthesis of polypeptide. In agreement with the results of Liu (1995), the present 
study shows that the 3'-CCA variants with terminal purines are active valine donors in 
polypeptide synthesis whereas C76 and U76 tRNA^*^ variants are poor valine donors (Figure 
14) (see also Liu and Horowitz, 1994). Even though C76 and U76 tRNA^*' variants are 
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highly active in aminoacylation, they are inactive valine donors for polypeptide synthesis 
(Figure 13). On the other hand, the G76 tRNA^** variant, which is a very poor substrate for 
aminoacylation, is an active valine donor in polypeptide synthesis, having 40% of the valine 
donor activity of wild-type tRNA^** (Figure 13 and 14). 
Interaction of Aminoacvl-tRNA and EF-Tu 
To identify the step or steps in the polypeptide chain elongation cycle at which the 
tRNA^*" mutants terminating in 3' pyrimidines, U76 and C76, fail to function, the interaction 
of aminoacylated mutant tRNAs with EF-Tu: GTP was examined by a hydrolysis protection 
assay in which interaction of aminoacyl-tRNA with EF-Tu:GTP protects the labile aminoacyl 
linkage from hydrolysis (see Methods). 
Specific recognition of 3'-terminal base of valvl-tRNA^** bv EF-Tu: GTP 
The hydrolysis protection assay is a reliable qualitative measure of aminoacyl-
tRNA/EF-Tu:GTP interaction. A similar hydrolysis protection assay was used to show that a 
10 base-pair helix linked to the 3'-NCCA sequence is the minimal helical length for efficient 
interaction with elongation factor Tu (Rudinger et al., 1994). The results of the hydrolysis 
protection experiments (Figure 15) clearly indicate that the tRNA^"* mutant with a 3'-terminal 
cytidine is discriminated against in the formation of a ternary complex. The rates of 
hydrolysis of C76 valyl-tRNA^®* in the presence and absence of EF-Tu:GTP are almost 
indistinguishable (Figure 15). To a lesser degree, EF-Tu:GTP also shows a decreased aflSnity 
for the U76 mutant of valyl-tRNA^*'. On the other hand, both wild type (A76) and the G76 
mutant of valyl-tRNA^"* have high affinities for EF-Tu), as indicated by the complete 
protection of both valyl-tRNA^'' from spontaneous hydrolysis in the presence of EF-Tu: GTP 
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(Figure 15). Similar results were observed with 3'-terminal mutants of E. colt alanyl-tRNA'^" 
and phenylalanyl-tRNA^® (Figures 18 and 20). Wild type (A76) and the G76 mutant of 
alanyl-tRNA'^' and phenylalanyl-tRNA^ show high aflBnities for EF-Tu. The presence of 3'-
terminal cytidine causes both aminoacyl-tRNAs to lose their affinity for EF-Tu. The U76 
mutant of phenylalanyl-tRNA was protected unexpectedly well in the hydrolysis assay. It 
appears that the presence of pyrimidines, especially cytidine, in the 3'-terminal position of 
aminoacyl-tRNA inhibit the formation of the ternary complex. 
The aminoacyl ester bond of valyl-tRNA^"* has a half-life of about one hour at pH 8 .0 
(Figure 15). Binding of aminoacyl-tRNA to EF-Tu; GTP inhibits the rate of this spontaneous 
hydrolysis (Pingoud and Urbanke, 1980). The molecular details of this protection are not 
known (Rudinger et ai, 1994), and in the time range used for this assay (180 minutes) the 
intrinsic GTPase activity of EF-Tu converts a considerable amount of GTP to GDP (Chinali 
etai, 1977). This reaction can affect the equilibrium for ternary complex formation. The 
data for the hydrolysis protection assays, should therefore, be considered only as a qualitative 
demonstration of the presence or the absence of the interaction between aminoacyl-tRNA and 
EF-Tu; GTP. 
Kd discrimination of 3'-terminal base of valvl-tRNA^*' 
Quantitative determination of the dissociation constants of ternary complexes 
between EF-Tu: GTP and 3'-CCA variants of tRNA^** was carried out using a ribonuclease 
protection assay (Table 8). This method was first developed by Louie and Jumak (1985) and 
was used to determine the dissociation constants of ternary complexes with the complete set 
of aminoacyl-tRNAs including at least one tRNA coding for each of the 20 amino acids. In 
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the present study, the dissociation constant (Kd) of the ternary complex with native modified 
vaiyl-tRNA^** was determined to be 8 nM (Table 8), a value which agrees well with that of 
7.1 nM reported by Louie and Jumak, (1985). Valyl-tRNA^** forms the weakest complex of 
all noninitiator EF-Tu:GTP;aminoacyl-tRNA complexes. This may reflea the fact that the 
ester linkage of valyl-tRNA^®' is the most stable among all aminoacyl-tRNAs. In vitro 
transcribed wild-type valyl-tRNA^** has a 2.75-fold higher Kd, 22 nM (Table 8). Nazarenko 
et al. (1994) reported that the BQ for the ternary complex with unmodified yeast 
phenylalanyl-tRNA^ is two-fold higher than that of the native counterpart. These results 
indicate that nucleotide modifications in tRNA increase the aflSnity of EF-Tu.GTP for 
aminoacyl-tRNA. 
C76 valyl-tRNA^** variant interacts poorly with EF-Tu as indicated earlier by the 
hydrolysis protection assay. This poor interaction makes determination of the dissociation 
constant of the ternary complex with the C76 valyl-tRNA variant inaccurate, and the IQ was 
estimated to be in the micromolar range, which is at least 45-fold higher than the Kj for the 
ternary complex involving wild-type valyl-tRNA^"* (Table 8). Even though U76 mutants of 
the various aminoacyl-tRNAs tested showed substantial affinity for EF-Tu.GTP, as indicated 
by their significant protection fi-om spontaneous hydrolysis in the presence of EF-Tu:GTP 
(Figure 15, 18 and 20), the dissociation constant of the ternary complex with U76 valyl-
tRNA^** is 16-fold higher, 351 nM, than the Kj of the ternary complex with wild-type valyl-
tRNA^** (Table 8). This difference in Kj is significant and compares with similar values 
obtained with the initiator tRNA*^'®* (Louie and Jumak, 1985). Initiator methionyl-tRNA*^*®' 
forms a weak complex with EF-Tu.GTP (Tanada et al., 1982). Its dissociation constant was 
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found to be 15.5-fold higher than that of the complex with native valyl-tRNA^*' (Louie and 
Jumak, 1985). This 15.5-fold increase in Kd is suflScient to prevent initiator methionyl-
tRNA'^'^ from participating in the translation elongation cycle. The authors indicate that the 
weaker ternary complex formation with initiator methionyl-tRNA^ is due to a faster 
dissociation of the errant complex. This suggests that EF-Tu;GTP initially recognizes all 
aminoacyl-tRNAs ahnost equivalently, but that proper selection of the noninitiator 
aminoacyl-tRNAs occurs by the rapid rejection of the initiator tRNA species. 
We now have a possible explanation for the observation that the C76 and U76 valyl-
tRNA^** variants are inactive valine donors in in vitro polypeptide synthesis. A pyrimidine at 
the 3'-terminal position of valyl-tRNA^*^ is discriminated against because elongation fector 
Tu specifically recognize a purine at this position. The inability of the C76 and U76 valyl-
tRNA^** variants to form ternary complexes with EF-Tu:GTP excludes them from 
participating in the elongation process. This conclusion is based on the protection of the 
wild-type and G76 valyl-tRNA^** variants by EF-Tu against deacylation and the lack of 
protection of the C76 and U76 valyl-tRNA^*' variants, and on the determination of 
dissociation constants for the interaction of various valyl-tRNA^*' variams with EF-Tu;GTP. 
However, this study does not rule out the possibility that C76 and U76 valyl-tRNA^*' are also 
inactive in other steps of the elongation cycle, such as the peptidyltransferase reaction and 
translocation. In addition, we found that the specific recognition of a purine at the 3'-
terminal position of aminoacyl-tRNA is general because the hydrolysis protection assay with 
3'-terminal variants of E. coli alanyl-tRNA'^ and phenylalanyl-tRNA*^ show results similar 
to those with the 3'-terminal variants of valyl-tRNA^ 
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What is the molecular basis for the specific recognition of a purine at the 3'-terminal 
position of aminoacyl-tRNA by EF-Tu? When comparing the four bases (adenine, guanine, 
cytosine, and uracil) in regard to the geometric location of flmctional groups and the potential 
hydrogen bonding donors and acceptors on each base, only the heterocyclic nitrogen at 
position 7 on adenine and guanine distinguishes the purines fi"om the pyrimidines. The 
recently available crystal structure of the ternary complex between yeast phenylalanyl-
tRNA^'' and EF-Tu (see Introduction) indicates that contacts between EF-Tu and 
phenylalanyl-tRNA"" are very limited. The 3'-terminal adenine of phenylalanyl-tRNA"", 
identified fi-om its electron density, is located in a hydrophobic pocket flanked by several 
hydrophobic amino acid residues of elongation factor Tu (see Introduction). No amino acid 
side chain of the protein appears to make specific contacts or forms any hydrogen bond with 
the fiinctional groups of the 3'-adenine (personal communication from Poul Nissen). 
Therefore, it is probably not the hydrogen bonding pattern on the 3'-terminal base of 
aminoacyl-tRNA that is recognized by EF-Tu. An analysis of the crystal structure of the 
ternary complex suggested that the hydrophobic platform in EF-Tu favors a purine base over 
a pyrimidine one, and the dipole alignment with Glu271 of EF-Tu favors adenine over 
guanine (Nissen et ai, 1996). These results agree well with our observed interactions 
between 3'-terminal variants of valyl-tRNA^** and EF-Tu:GTP. 
Interaction between positions 74 and 75 variants of valvl-tRNA^** and elongation factor Tu 
The ability of positions 74 and 75 variants of valyl-tRNA^** to participate in the 
polypeptide synthesis (Figure 14) indicate that mutants at these two positions are active in all 
steps of the elongation cycle. As expected, no dramatic effects on ternary complex formation 
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are observed upon making systematic changes at C74 and C75. as monitored by the 
hydrolysis protection assay and Kd determinations. EF-Tu:GTP fiilly protects all tRNA^** 
mutants at positions 74 and 75 from deacylation (Figures 16 and 17). The Kjs of ternary 
complexes with all tRNA^** mutants at positions 74 and 75 are very similar to the Kd of the 
complex with wild-type valyl-tRNA^** (Table 8). These results agree well with the crystal 
structure where only the phosphates of C74 and C75 interact with Lys52 of EF-Tu, while the 
bases of A73, C74 and C75 are stacked in continuation of the acceptor helix without any 
specific interaction with the protein (Nissen, 1995). Therefore, all mutations at positions 74 
and 75 in this study, as well as many base modifications at these two positions fi'om other 
studies (Baksht et al., 1977) can be accommodated by EF-Tu in formation of ternary 
complexes. 
This study has shown that the 3'-terminal base of a tRNA is specifically recognized by 
elongation factor Tu. The amino acid residues in the pocket of EF-Tu that interacts with the 
3'-end of aminoacyl-tRNA, discriminate against pyrimidines and only allow purines at the 3'-
terminal position. These results agree well with the observation that C76 and U76 valyl-
tRNA^"* are unable to participate in polypeptide synthesis, while G76 valyl-tRNA^®* is an 
active participant in polypeptide synthesis. 
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